BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531-538. [PMID: 32161990 DOI: 10.1007/s00392-020-01626-9] [Cited by in Crossref: 762] [Cited by in F6Publishing: 607] [Article Influence: 762.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohamed Abdel Shafi A, Hewage S, Harky A. The impact of COVID-19 on the provision of cardiac surgical services. J Card Surg 2020;35:1295-7. [PMID: 32419218 DOI: 10.1111/jocs.14631] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
2 Fervers P, Kottlors J, Große Hokamp N, Bremm J, Maintz D, Tritt S, Safarov O, Persigehl T, Vollmar N, Bansmann PM, Abdullayev N. Coronary artery calcification on low-dose chest CT is an early predictor of severe progression of COVID-19-A multi-center, multi-vendor study. PLoS One 2021;16:e0255045. [PMID: 34288966 DOI: 10.1371/journal.pone.0255045] [Reference Citation Analysis]
3 Ekrami E, Pouresmaieli M, Barati F, Asghari S, Ziarani FR, Shariati P, Mamoudifard M. Potential Diagnostic Systems for Coronavirus Detection: a Critical Review. Biol Proced Online 2020;22:21. [PMID: 32884452 DOI: 10.1186/s12575-020-00134-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
4 Shin CH, Kim KH, Jeeva S, Kang SM. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021;10:1412. [PMID: 34204163 DOI: 10.3390/cells10061412] [Reference Citation Analysis]
5 Koupenova M, Freedman JE. Platelets and COVID-19: Inflammation, Hyperactivation and Additional Questions. Circ Res 2020;127:1419-21. [PMID: 33151798 DOI: 10.1161/CIRCRESAHA.120.318218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
6 Briguglio M, Porta M, Zuffada F, Bona AR, Crespi T, Pino F, Perazzo P, Mazzocchi M, Giorgino R, De Angelis G, Ielasi A, De Blasio G, Turiel M. SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19. Front Physiol 2020;11:571367. [PMID: 33240098 DOI: 10.3389/fphys.2020.571367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Pelle MC, Tassone B, Ricchio M, Mazzitelli M, Davoli C, Procopio G, Cancelliere A, La Gamba V, Lio E, Matera G, Quirino A, Barreca GS, Trecarichi EM, Torti C; IDTM UMG COVID-19 Group. Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report. J Med Case Rep 2020;14:246. [PMID: 33339534 DOI: 10.1186/s13256-020-02595-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sisti N, Valente S, Mandoli GE, Santoro C, Sciaccaluga C, Franchi F, Cameli P, Mondillo S, Cameli M. COVID-19 in patients with heart failure: the new and the old epidemic. Postgrad Med J 2021;97:175-9. [PMID: 32732260 DOI: 10.1136/postgradmedj-2020-138080] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
9 Perel P, Grobbee DE. The Heart in the Time of the 'Coronavirus'. Glob Heart 2020;15:24. [PMID: 32489797 DOI: 10.5334/gh.786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Miftode RS, Petriș AO, Onofrei Aursulesei V, Cianga C, Costache II, Mitu O, Miftode IL, Șerban IL. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics (Basel) 2021;11:175. [PMID: 33530550 DOI: 10.3390/diagnostics11020175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-Analysis. SSRN. 2020;3566166. [PMID: 32714109 DOI: 10.2139/ssrn.3566166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 15.0] [Reference Citation Analysis]
12 Shi S, Qin M, Yang B. Coronavirus Disease 2019 (COVID-19) and Cardiac Injury-Reply. JAMA Cardiol 2020;5:1199-200. [PMID: 32639516 DOI: 10.1001/jamacardio.2020.2456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
13 Satsangi S, Gupta N, Kodan P. Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver. J Clin Transl Hepatol 2021;9:436-46. [PMID: 34221930 DOI: 10.14218/JCTH.2020.00174] [Reference Citation Analysis]
14 Alamdari NM, Rahimi FS, Afaghi S, Zarghi A, Qaderi S, Tarki FE, Ghafouri SR, Besharat S. The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients. Diabetes Metab Syndr 2020;14:1979-86. [PMID: 33080538 DOI: 10.1016/j.dsx.2020.10.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sifunda S, Mokhele T, Manyaapelo T, Dukhi N, Sewpaul R, Parker WA, Parker S, Naidoo I, Jooste S, Ramlagan S, Gaida R, Mabaso M, Zuma K, Reddy P. Preparedness for self-isolation or quarantine and lockdown in South Africa: results from a rapid online survey. BMC Public Health 2021;21:580. [PMID: 33757461 DOI: 10.1186/s12889-021-10628-9] [Reference Citation Analysis]
16 Deng L, Zhang J, Wang M, Chen L. Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis. Epidemiol Infect 2021;149:e144. [PMID: 33397542 DOI: 10.1017/S0950268820003179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
18 Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504-7. [PMID: 32317203 DOI: 10.1016/j.ajem.2020.04.048] [Cited by in Crossref: 275] [Cited by in F6Publishing: 201] [Article Influence: 275.0] [Reference Citation Analysis]
19 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 263] [Cited by in F6Publishing: 144] [Article Influence: 263.0] [Reference Citation Analysis]
20 Feldman C. Cardiac complications in community-acquired pneumonia and COVID-19. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235421 DOI: 10.7196/AJTCCM.2020.v26i2.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Fernandez-Fernandez B, D'Marco L, Górriz JL, Jacobs-Cachá C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19. J Clin Med 2020;9:E2030. [PMID: 32605278 DOI: 10.3390/jcm9072030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
22 Scott ES, Jenkins AJ, Fulcher GR. Challenges of diabetes management during the COVID-19 pandemic. Med J Aust 2020;213:56-57.e1. [PMID: 32583422 DOI: 10.5694/mja2.50665] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
23 Tian C, Li N, Bai Y, Xiao H, Li S, Ge QG, Shen N, Ma QB. Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension. World J Clin Cases 2021;9:47-60. [PMID: 33511171 DOI: 10.12998/wjcc.v9.i1.47] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gautam V, S D, Rustagi N, Mittal A, Patel M, Shafi S, Thirunavukkarasu P, Raghav P. Health literacy, preventive COVID 19 behaviour and adherence to chronic disease treatment during lockdown among patients registered at primary health facility in urban Jodhpur, Rajasthan. Diabetes Metab Syndr 2021;15:205-11. [PMID: 33387854 DOI: 10.1016/j.dsx.2020.12.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Shah V, Keniya R, Shridharani A, Punjabi M, Shah J, Mehendale N. Diagnosis of COVID-19 using CT scan images and deep learning techniques. Emerg Radiol 2021;28:497-505. [PMID: 33523309 DOI: 10.1007/s10140-020-01886-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
26 Turrini M, Gardellini A, Beretta L, Buzzi L, Ferrario S, Vasile S, Clerici R, Colzani A, Liparulo L, Scognamiglio G, Imperiali G, Corrado G, Strada A, Galletti M, Castiglione N, Zanon C. Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy. Vaccines (Basel) 2021;9:640. [PMID: 34208017 DOI: 10.3390/vaccines9060640] [Reference Citation Analysis]
27 Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics 2020;52:549-57. [PMID: 32991251 DOI: 10.1152/physiolgenomics.00089.2020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 30.0] [Reference Citation Analysis]
28 Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A, Dorostkar R, Tat M, Shahriary A, Farnoosh G, Hosseini Zijoud SR, Taghdir M, Alimohamadi Y, Abbaszadeh S, Gouvarchin Ghaleh HE, Bagheri M. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol 2020;127:104378. [PMID: 32353762 DOI: 10.1016/j.jcv.2020.104378] [Cited by in Crossref: 134] [Cited by in F6Publishing: 97] [Article Influence: 134.0] [Reference Citation Analysis]
29 Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological Impact of Myocarditis. J Clin Med 2021;10:603. [PMID: 33562759 DOI: 10.3390/jcm10040603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Knepple Carney A, Graf AS, Hudson G, Wilson E. Age Moderates Perceived COVID-19 Disruption on Well-Being. Gerontologist 2021;61:30-5. [PMID: 32808660 DOI: 10.1093/geront/gnaa106] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
31 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 28.0] [Reference Citation Analysis]
32 Dzobo K. Coronavirus Disease 19 and Future Ecological Crises: Hopes from Epigenomics and Unraveling Genome Regulation in Humans and Infectious Agents. OMICS 2021;25:269-78. [PMID: 33904782 DOI: 10.1089/omi.2021.0024] [Reference Citation Analysis]
33 Lemke MK, Apostolopoulos Y, Sönmez S. A novel COVID-19 based truck driver syndemic? Implications for public health, safety, and vital supply chains. Am J Ind Med 2020;63:659-62. [PMID: 32452556 DOI: 10.1002/ajim.23138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
34 Manolis AS, Manolis TA, Manolis AA, Melita H. Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down. Curr Opin Cardiol 2021;36:241-51. [PMID: 33395080 DOI: 10.1097/HCO.0000000000000838] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ahmed S, Gasparyan AY, Zimba O. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 2021;41:243-56. [PMID: 33388969 DOI: 10.1007/s00296-020-04764-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
36 Bhatia M, Kumar PA. Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19. J Cardiothorac Vasc Anesth 2021;35:703-6. [PMID: 33288430 DOI: 10.1053/j.jvca.2020.11.027] [Reference Citation Analysis]
37 Zaldo-Aubanell Q, Campillo I López F, Bach A, Serra I, Olivet-Vila J, Saez M, Pino D, Maneja R. Community Risk Factors in the COVID-19 Incidence and Mortality in Catalonia (Spain). A Population-Based Study. Int J Environ Res Public Health 2021;18:3768. [PMID: 33916590 DOI: 10.3390/ijerph18073768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zubieta-Calleja G, Zubieta-DeUrioste N, Venkatesh T, Das KK, Soliz J. COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. Rev Recent Clin Trials 2020;15:347-59. [PMID: 32981508 DOI: 10.2174/1574887115666200925141108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
39 Singh AK, Misra A. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India. Diabetes Metab Syndr 2020;14:1625-30. [PMID: 32891011 DOI: 10.1016/j.dsx.2020.08.032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 33.0] [Reference Citation Analysis]
40 Darwesh AM, Bassiouni W, Sosnowski DK, Seubert JM. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol Ther 2021;219:107703. [PMID: 33031856 DOI: 10.1016/j.pharmthera.2020.107703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
41 Suzuki YJ, Gychka SG. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines (Basel) 2021;9:36. [PMID: 33440640 DOI: 10.3390/vaccines9010036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
42 Vlachakis PK, Tentolouris A, Tousoulis D, Tentolouris N. Current data on the cardiovascular effects of COVID-19. Hellenic J Cardiol 2020;61:46-8. [PMID: 32315757 DOI: 10.1016/j.hjc.2020.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
43 Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020;39:101044. [PMID: 32585364 DOI: 10.1016/j.molmet.2020.101044] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 60.0] [Reference Citation Analysis]
44 Bhatia R, Srivastava MVP. COVID-19 and Stroke: Incidental, Triggered or Causative. Ann Indian Acad Neurol 2020;23:318-24. [PMID: 32606519 DOI: 10.4103/aian.AIAN_380_20] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
45 George JA, Maphayi MR, Pillay T. COVID-19 and Vulnerable Populations in Sub-Saharan Africa. Adv Exp Med Biol 2021;1321:147-62. [PMID: 33656721 DOI: 10.1007/978-3-030-59261-5_13] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ali S, Singh A, Sharief N, Yadav M, Siddiqui S, Pandey V, Raikwar A, Singh A. Coronaviruses: An overview with special emphasis on COVID-19 outbreak with musculoskeletal manifestations. WJO 2021;12:620-8. [DOI: 10.5312/wjo.v12.i9.620] [Reference Citation Analysis]
47 Borges do Nascimento IJ, O'Mathúna DP, von Groote TC, Abdulazeem HM, Weerasekara I, Marusic A, Puljak L, Civile VT, Zakarija-Grkovic I, Pericic TP, Atallah AN, Filoso S, Bragazzi NL, Marcolino MS; International Network of Coronavirus Disease 2019 (InterNetCOVID-19). Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews. BMC Infect Dis 2021;21:525. [PMID: 34088271 DOI: 10.1186/s12879-021-06214-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Guo L, Shi Z, Zhang Y, Wang C, Do Vale Moreira NC, Zuo H, Hussain A. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Diabetes Res Clin Pract 2020;166:108346. [PMID: 32710998 DOI: 10.1016/j.diabres.2020.108346] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
49 Mansour OY, Malik AM, Linfante I. Mechanical Thrombectomy of COVID-19 positive acute ischemic stroke patient: a case report and call for preparedness. BMC Neurol 2020;20:358. [PMID: 32972381 DOI: 10.1186/s12883-020-01930-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
50 Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, Wang Y. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis 2020;99:47-56. [PMID: 32721533 DOI: 10.1016/j.ijid.2020.07.029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 56] [Article Influence: 83.0] [Reference Citation Analysis]
51 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Reference Citation Analysis]
52 Messner W, Payson SE. Contextual factors and the COVID-19 outbreak rate across U.S. counties in its initial phase. Health Sci Rep 2021;4:e242. [PMID: 33553680 DOI: 10.1002/hsr2.242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
53 Harky A, Chen R, Pullan M. Examining the impact of COVID-19 on cardiac surgery services: The lessons learned from this pandemic. J Card Surg 2020;35:2364-6. [PMID: 32643830 DOI: 10.1111/jocs.14783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
54 Singh GP, Hrishi AP, Rath GP. Emergency neurological procedures during COVID-19 pandemic: Practical issues. J Anaesthesiol Clin Pharmacol 2020;36:S104-9. [PMID: 33100657 DOI: 10.4103/joacp.JOACP_243_20] [Reference Citation Analysis]
55 Teuben MPJ, Pfeifer R, Teuber H, De Boer LL, Halvachizadeh S, Shehu A, Pape HC. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review. Patient Saf Surg 2020;14:28. [PMID: 32665786 DOI: 10.1186/s13037-020-00253-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ky B, Mann DL. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities. JACC Basic Transl Sci 2020;5:501-17. [PMID: 32309679 DOI: 10.1016/j.jacbts.2020.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
57 Peters EMJ, Schedlowski M, Watzl C, Gimsa U. To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2. Neurobiol Stress 2021;14:100296. [PMID: 33527083 DOI: 10.1016/j.ynstr.2021.100296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
58 Busetto GM, Porreca A, Del Giudice F, Maggi M, D'Agostino D, Romagnoli D, Musi G, Lucarelli G, Palmer K, Colonna di Paliano A, Muto M, Hurle R, Terracciano D, de Cobelli O, Sciarra A, De Berardinis E, Ferro M. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features? Urol Int 2020;104:510-22. [PMID: 32516772 DOI: 10.1159/000509065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Florez-Perdomo WA, Serrato-Vargas SA, Bosque-Varela P, Moscote-Salazar LR, Joaquim AF, Agrawal A, Soto-Angel ÁR, Tovar-Montenegro LT. Relationship between the history of cerebrovascular disease and mortality in COVID-19 patients: A systematic review and meta-analysis. Clin Neurol Neurosurg 2020;197:106183. [PMID: 32919240 DOI: 10.1016/j.clineuro.2020.106183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
60 Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R. A Contemporary Review of Neurological Sequelae of COVID-19. Front Neurol 2020;11:640. [PMID: 32655489 DOI: 10.3389/fneur.2020.00640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 23.0] [Reference Citation Analysis]
61 Bottio T, Bagozzi L, Fiocco A, Nadali M, Caraffa R, Bifulco O, Ponzoni M, Lombardi CM, Metra M, Russo CF, Frigerio M, Masciocco G, Potena L, Loforte A, Pacini D, Faggian G, Onorati F, Sponga S, Livi U, Iacovoni A, Terzi A, Senni M, Rinaldi M, Boffini M, Marro M, Jorgji V, Carrozzini M, Gerosa G. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. JACC Heart Fail 2021;9:52-61. [PMID: 33309578 DOI: 10.1016/j.jchf.2020.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
62 Nigro E, Perrotta F, Polito R, D'Agnano V, Scialò F, Bianco A, Daniele A. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways. Int J Endocrinol 2020;2020:8896536. [PMID: 33312199 DOI: 10.1155/2020/8896536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Nguyen QC, Huang Y, Kumar A, Duan H, Keralis JM, Dwivedi P, Meng HW, Brunisholz KD, Jay J, Javanmardi M, Tasdizen T. Using 164 Million Google Street View Images to Derive Built Environment Predictors of COVID-19 Cases. Int J Environ Res Public Health 2020;17:E6359. [PMID: 32882867 DOI: 10.3390/ijerph17176359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 18.0] [Reference Citation Analysis]
64 Galiuto L, Crea F. Let Us Not Forget Cardiovascular Diseases During COVID-19 Pandemic: the Role of Cardiac Prevention and Rehabilitation. SN Compr Clin Med 2020;:1-4. [PMID: 32838162 DOI: 10.1007/s42399-020-00391-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract 2020;165:108266. [PMID: 32533989 DOI: 10.1016/j.diabres.2020.108266] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 25.0] [Reference Citation Analysis]
66 Williams DM, Nawaz A, Evans M. Diabetes and Novel Coronavirus Infection: Implications for Treatment. Diabetes Ther 2020;11:1915-24. [PMID: 32661881 DOI: 10.1007/s13300-020-00858-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Sharif N, Opu RR, Ahmed SN, Sarkar MK, Jaheen R, Daullah MU, Khan S, Mubin M, Rahman H, Islam F, Haque N, Islam S, Khan FB, Haque N, Ayman U, Shohael AM, Dey SK, Talukder AA. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave. Diabetes Metab Syndr 2021;15:102148. [PMID: 34186349 DOI: 10.1016/j.dsx.2021.05.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Feitosa MR, Parra RS, de Camargo HP, Ferreira SDC, Troncon LEA, da Rocha JJR, Féres O. COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil. Ann Gastroenterol 2021;34:39-45. [PMID: 33414620 DOI: 10.20524/aog.2020.0558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kashyap S, Bala R, Madaan R, Behl T. Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach. Environ Sci Pollut Res Int 2021;28:35429-36. [PMID: 34021454 DOI: 10.1007/s11356-021-14480-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Chakraborty R, Parvez S. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials. Biochem Pharmacol 2020;180:114184. [PMID: 32739342 DOI: 10.1016/j.bcp.2020.114184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 24.0] [Reference Citation Analysis]
71 Tai S, Tang J, Yu B, Tang L, Wang Y, Zhang H, Zhu W, Xiao K, Wen C, Tan C, Jiang Z, Jiang C, Zhu L, Jiang L, Liu Q, Hu X, Fang Z, Li X, Sun J, Zhu Z, Yang H, Tu T, Xiao Y, Chen M, He Y, Chai X, Xu J, Zhou S. Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19. Cardiovasc Ther 2020;2020:9059562. [PMID: 32874203 DOI: 10.1155/2020/9059562] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Feng X, Xie X, Song S, Chen W, Bian H, Rui F, Zhu Q, Ren W, Qin C, Qi J. Current directions, conceptions and viewpoints on 2019-nCoV (Review). Exp Ther Med 2021;21:70. [PMID: 33365070 DOI: 10.3892/etm.2020.9502] [Reference Citation Analysis]
73 Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract 2020;166:108293. [PMID: 32623035 DOI: 10.1016/j.diabres.2020.108293] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 34.0] [Reference Citation Analysis]
74 Mishra Y, Pathak BK, Mohakuda SS, Tilak TVSVGK, Sen S, P H, Singh R, Singh AR. Relation of D-dimer levels of COVID-19 patients with diabetes mellitus. Diabetes Metab Syndr 2020;14:1927-30. [PMID: 33035824 DOI: 10.1016/j.dsx.2020.09.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
75 Loungani RS, Rehorn MR, Newby LK, Katz JN, Klem I, Mentz RJ, Jones WS, Vemulapalli S, Kelsey AM, Blazing MA, Piccini JP, Patel MR. A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response. Am Heart J 2020;225:3-9. [PMID: 32417526 DOI: 10.1016/j.ahj.2020.04.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
76 Alberca RW, Oliveira LM, Branco ACCC, Pereira NZ, Sato MN. Obesity as a risk factor for COVID-19: an overview. Crit Rev Food Sci Nutr. 2020;1-15. [PMID: 32539446 DOI: 10.1080/10408398.2020.1775546] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 34.0] [Reference Citation Analysis]
77 Magadum A, Kishore R. Cardiovascular Manifestations of COVID-19 Infection. Cells 2020;9:E2508. [PMID: 33228225 DOI: 10.3390/cells9112508] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 25.0] [Reference Citation Analysis]
78 Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29:104949. [PMID: 32410807 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104949] [Cited by in Crossref: 154] [Cited by in F6Publishing: 120] [Article Influence: 154.0] [Reference Citation Analysis]
79 Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One 2020;15:e0238215. [PMID: 32845926 DOI: 10.1371/journal.pone.0238215] [Cited by in Crossref: 123] [Cited by in F6Publishing: 97] [Article Influence: 123.0] [Reference Citation Analysis]
80 Khan H, Chowdhury A, Lasker SS, Chowdhury TA. The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey. Diabetes Res Clin Pract 2020;169:108476. [PMID: 33002549 DOI: 10.1016/j.diabres.2020.108476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Baracchini C, Pieroni A. Acute stroke treatment during coronavirus disease 2019 pandemic. Curr Opin Neurol 2021;34:11-7. [PMID: 33196578 DOI: 10.1097/WCO.0000000000000886] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
82 Unnikrishnan R, Misra A. Infections and diabetes: Risks and mitigation with reference to India. Diabetes Metab Syndr 2020;14:1889-94. [PMID: 33002780 DOI: 10.1016/j.dsx.2020.09.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
83 Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms. Int J Endocrinol 2021;2021:7394378. [PMID: 33859687 DOI: 10.1155/2021/7394378] [Reference Citation Analysis]
84 Reichert KP, Castro MFV, Assmann CE, Bottari NB, Miron VV, Cardoso A, Stefanello N, Morsch VMM, Schetinger MRC. Diabetes and hypertension: Pivotal involvement of purinergic signaling. Biomed Pharmacother 2021;137:111273. [PMID: 33524787 DOI: 10.1016/j.biopha.2021.111273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Bertin D, Brodovitch A, Beziane A, Hug S, Bouamri A, Mege JL, Heim X, Bardin N. Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity. Arthritis Rheumatol 2020;72:1953-5. [PMID: 32564467 DOI: 10.1002/art.41409] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 34.0] [Reference Citation Analysis]
86 Lo Bianco G, Di Pietro S, Mazzuca E, Imburgia A, Tarantino L, Accurso G, Benenati V, Vernuccio F, Bucolo C, Salomone S, Riolo M. Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review. Front Pharmacol 2020;11:572168. [PMID: 33362541 DOI: 10.3389/fphar.2020.572168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Dalia T, Lahan S, Ranka S, Acharya P, Gautam A, Goyal A, Mastoris I, Sauer A, Shah Z. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis. Indian Heart J 2021;73:91-8. [PMID: 33714416 DOI: 10.1016/j.ihj.2020.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
88 Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, Hota P. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging 2021;77:1-8. [PMID: 33601125 DOI: 10.1016/j.clinimag.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020;309:70-7. [PMID: 32248966 DOI: 10.1016/j.ijcard.2020.03.063] [Cited by in Crossref: 126] [Cited by in F6Publishing: 98] [Article Influence: 126.0] [Reference Citation Analysis]
90 Mohamadi M, Goodarzi A, Aryannejad A, Fattahi N, Alizadeh-Khoei M, Miri S, Hekmat H, Payab M, Bodaghabadi M. Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review. Med J Islam Repub Iran 2020;34:123. [PMID: 33437719 DOI: 10.34171/mjiri.34.123] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
91 Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The Immune Response and Immunopathology of COVID-19. Front Immunol 2020;11:2037. [PMID: 32983152 DOI: 10.3389/fimmu.2020.02037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 31.0] [Reference Citation Analysis]
92 Beran D, Aebischer Perone S, Castellsague Perolini M, Chappuis F, Chopard P, Haller DM, Jacquerioz Bausch F, Maisonneuve H, Perone N, Gastaldi G. Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19. Prim Care Diabetes 2021;15:16-7. [PMID: 32535088 DOI: 10.1016/j.pcd.2020.05.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
93 Baidya A, Singh SK, Bajaj S, Zargar AH, Singh P, Das S, Shankar A. Diabetes and COVID-19: A Review. J ASEAN Fed Endocr Soc 2020;35:40-8. [PMID: 33442168 DOI: 10.15605/jafes.035.01.06] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich) 2020;22:943-8. [PMID: 32472662 DOI: 10.1111/jch.13912] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 29.0] [Reference Citation Analysis]
95 Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep 2021;11:6375. [PMID: 33737679 DOI: 10.1038/s41598-021-85813-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
96 Wang M, Wu T, Zuo Z, You Y, Yang X, Pan L, Hu Y, Luo X, Jiang L, Xia Z, Deng M. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. BMJ Support Palliat Care 2021;11:45-52. [PMID: 32958501 DOI: 10.1136/bmjspcare-2020-002554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
97 Hosseinzadeh R, Goharrizi MASB, Bahardoust M, Alvanegh AG, Ataee MR, Bagheri M, Navidiyan ES, Zijoud SRH, Heiat M. Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clin Hypertens 2021;27:3. [PMID: 33451360 DOI: 10.1186/s40885-021-00161-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol 2020;27:363-70. [PMID: 32732586 DOI: 10.1097/PAP.0000000000000276] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
99 [DOI: 10.1101/2020.10.09.20207464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
100 Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ 2020;29:973-87. [PMID: 32601020 DOI: 10.1016/j.hlc.2020.05.101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 33.0] [Reference Citation Analysis]
101 Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, Lu Z, Chen J, Chen Z, Chen S, Tong J, Xiao W, Mei J, Lu H. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY) 2020;12:15670-81. [PMID: 32805722 DOI: 10.18632/aging.103770] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
102 Rodríguez-Molinero A, Gálvez-Barrón C, Miñarro A, Macho O, López GF, Robles MT, Dapena MD, Martínez S, Milà Ràfols N, Monaco EE, Hidalgo García A; COVID-19 Research Group of CSAPG. Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PLoS One 2020;15:e0239571. [PMID: 33057443 DOI: 10.1371/journal.pone.0239571] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
103 Park BE, Lee JH, Park HK, Kim HN, Jang SY, Bae MH, Yang DH, Park HS, Cho Y, Lee BY, Nam CW, Lee JB, Kim U, Chae SC; Daegu COVID-19 Research Project. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. J Korean Med Sci 2021;36:e15. [PMID: 33429474 DOI: 10.3346/jkms.2021.36.e15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Li L, Zhou Q, Xu J. Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019. Biomed Res Int 2020;2020:7413673. [PMID: 32596365 DOI: 10.1155/2020/7413673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
105 Helgeson SA, Taylor BJ, Lim KG, Lee AS, Niven AS, Patel NM. Characterizing Particulate Generation During Cardiopulmonary Rehabilitation Classes With Patients Wearing Procedural Masks. Chest 2021;160:633-41. [PMID: 33667490 DOI: 10.1016/j.chest.2021.02.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Zhou W, Liu Y, Xu B, Wang S, Li S, Liu H, Huang Z, Luo Y, Hu M, Wu W, Zhang Z, Long X, Zou W, Bian Y, Zou X, Elliott M, Yue L, Deng H, Chen H, Gao X, Wu Y, Fang M, Zhang B, Gao Y. Early identification of patients with severe COVID-19 at increased risk of in-hospital death: a multicenter case-control study in Wuhan. J Thorac Dis 2021;13:1380-95. [PMID: 33841931 DOI: 10.21037/jtd-20-2568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. Am J Otolaryngol 2020;41:102473. [PMID: 32276732 DOI: 10.1016/j.amjoto.2020.102473] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 41.0] [Reference Citation Analysis]
108 Liu WY, Chuang YC, Liu TJ, Chien CW, Tung TH. Insights from the comparisons of SARS-CoV and COVID-19 outbreaks: The evidence-based experience of epidemic prevention in China. Medicine (Baltimore) 2021;100:e24650. [PMID: 33578592 DOI: 10.1097/MD.0000000000024650] [Reference Citation Analysis]
109 [DOI: 10.1101/2020.04.10.20060335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, Bonten MMJ, Damen JAA, Debray TPA, De Vos M, Dhiman P, Haller MC, Harhay MO, Henckaerts L, Kreuzberger N, Lohman A, Luijken K, Ma J, Andaur CL, Reitsma JB, Sergeant JC, Shi C, Skoetz N, Smits LJM, Snell KIE, Sperrin M, Spijker R, Steyerberg EW, Takada T, van Kuijk SMJ, van Royen FS, Wallisch C, Hooft L, Moons KGM, van Smeden M. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. [PMID: 32265220 DOI: 10.1136/bmj.m1328] [Cited by in Crossref: 805] [Cited by in F6Publishing: 672] [Article Influence: 805.0] [Reference Citation Analysis]
111 Tibirica E, De Lorenzo A. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19. Microvasc Res 2020;131:104028. [PMID: 32531352 DOI: 10.1016/j.mvr.2020.104028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
112 Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C. A systematic review of neurological symptoms and complications of COVID-19. J Neurol 2021;268:392-402. [PMID: 32691236 DOI: 10.1007/s00415-020-10067-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 40.0] [Reference Citation Analysis]
113 Brant LCC, Nascimento BR, Teixeira RA, Lopes MACQ, Malta DC, Oliveira GMM, Ribeiro ALP. Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities. Heart 2020;106:1898-905. [PMID: 33060261 DOI: 10.1136/heartjnl-2020-317663] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
114 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Holly JMP, Biernacka K, Maskell N, Perks CM. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle. Front Endocrinol (Lausanne) 2020;11:582870. [PMID: 33042029 DOI: 10.3389/fendo.2020.582870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
116 Zhuang J, Yin J, Lv S, Wang B, Mu Y. Advanced "lab-on-a-chip" to detect viruses - Current challenges and future perspectives. Biosens Bioelectron 2020;163:112291. [PMID: 32421630 DOI: 10.1016/j.bios.2020.112291] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 33.0] [Reference Citation Analysis]
117 Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, White A, Salvo GD, Sade LE, Pearce K, Newby DE, Popescu BA, Donal E, Cosyns B, Edvardsen T, Mills NL, Haugaa K. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging 2020;21:949-58. [PMID: 32556199 DOI: 10.1093/ehjci/jeaa178] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 107.0] [Reference Citation Analysis]
118 Ogunjimi M, Haiduc AA, Harky A. Congenital heart disease and incremental risks of COVID-19. J Card Surg 2021;36:433-5. [PMID: 33331065 DOI: 10.1111/jocs.15246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Hanif S, Ali SN, Hassanein M, Khunti K, Hanif W. Managing People with Diabetes Fasting for Ramadan During the COVID-19 Pandemic: A South Asian Health Foundation Update. Diabet Med 2020;37:1094-102. [PMID: 32333691 DOI: 10.1111/dme.14312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
120 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
121 Conway J, Gould A, Westley R, Raju SA, Oklopcic A, Broadbent A, Abdelhafiz AH, Sinclair AJ. Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report. Diabetes Res Clin Pract 2020;169:108460. [PMID: 32971153 DOI: 10.1016/j.diabres.2020.108460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
122 Alwaqfi NR, Ibrahim KS. COVID-19: an update and cardiac involvement. J Cardiothorac Surg 2020;15:239. [PMID: 32907637 DOI: 10.1186/s13019-020-01299-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
123 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
124 Baracchini C, Pieroni A, Kneihsl M, Azevedo E, Diomedi M, Pascazio L, Wojczal J, Lucas C, Bartels E, Bornstein NM, Csiba L, Valdueza J, Tsivgoulis G, Malojcic B. Practice recommendations for neurovascular ultrasound investigations of acute stroke patients in the setting of the COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics. Eur J Neurol. 2020;27:1776-1780. [PMID: 32426890 DOI: 10.1111/ene.14334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
125 Silva I, Faria NC, Ferreira ÁRS, Anastácio LR, Ferreira LG. Risk factors for critical illness and death among adult Brazilians with COVID-19. Rev Soc Bras Med Trop 2021;54:e0014 2021. [PMID: 33950121 DOI: 10.1590/0037-8682-0014-2021] [Reference Citation Analysis]
126 Patoulias D, Papadopoulos C, Boulmpou A, Doumas M. Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic. Diabetes Obes Metab 2021;23:1696-700. [PMID: 33606909 DOI: 10.1111/dom.14359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Ryan JJ, Melendres-Groves L, Zamanian RT, Oudiz RJ, Chakinala M, Rosenzweig EB, Gomberg-Maitland M. Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic. Pulm Circ 2020;10:2045894020920153. [PMID: 32426111 DOI: 10.1177/2045894020920153] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 29.0] [Reference Citation Analysis]
128 Khatri A, Wallach F. Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: A case report and literature review. Heart Lung 2020;49:858-63. [PMID: 32693958 DOI: 10.1016/j.hrtlng.2020.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
129 Tufik S, Gozal D, Ishikura IA, Pires GN, Andersen ML. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity? J Clin Sleep Med 2020;16:1425-6. [PMID: 32441246 DOI: 10.5664/jcsm.8596] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
130 Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight 2021;6:148980. [PMID: 34061779 DOI: 10.1172/jci.insight.148980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Pallarés Carratalá V, Górriz-Zambrano C, Morillas Ariño C, Llisterri Caro JL, Gorriz JL. [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]. Semergen 2020;46 Suppl 1:78-87. [PMID: 32448633 DOI: 10.1016/j.semerg.2020.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
132 Santos J, Brierley S, Gandhi MJ, Cohen MA, Moschella PC, Declan ABL. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review. Viruses 2020;12:E705. [PMID: 32629804 DOI: 10.3390/v12070705] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
133 Lewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study. Arch Med Sci 2021;17:818-22. [PMID: 34025853 DOI: 10.5114/aoms/134211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Virgens IPA, Santana NM, Lima SCVC, Fayh APT. Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. Br J Nutr 2021;126:552-60. [PMID: 33261670 DOI: 10.1017/S0007114520004420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
135 Tavazzi G, Corradi F, Mojoli F, Forfori F, Via G. Contextualizing cardiac dysfunction in critically ill patients with COVID-19. Minerva Anestesiol 2020;86:1340-5. [PMID: 33174406 DOI: 10.23736/S0375-9393.20.14859-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
136 Katsiki N, Banach M, Mikhailidis DP. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic. Arch Med Sci 2020;16:485-9. [PMID: 32399093 DOI: 10.5114/aoms.2020.94503] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 30.0] [Reference Citation Analysis]
137 Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLoS One 2020;15:e0241953. [PMID: 33196669 DOI: 10.1371/journal.pone.0241953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
138 Agarwal MA, Ziaeian B, Lavie CJ, Fonarow GC. Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre-COVID-19 Era in United States: National Analysis From 2016-2017. Mayo Clin Proc 2020;95:2674-83. [PMID: 33276839 DOI: 10.1016/j.mayocp.2020.09.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
139 Cai CZ, Lin YL, Hu ZJ, Wong LP. Psychological and mental health impacts of COVID-19 pandemic on healthcare workers in China: A review. World J Psychiatry 2021;11:337-46. [PMID: 34327126 DOI: 10.5498/wjp.v11.i7.337] [Reference Citation Analysis]
140 Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20:529-536. [PMID: 32728222 DOI: 10.1038/s41577-020-0402-6] [Cited by in Crossref: 282] [Cited by in F6Publishing: 205] [Article Influence: 282.0] [Reference Citation Analysis]
141 de Oliveira BRB, da Penha Sobral AIG, Marinho MLM, Sobral MFF, de Souza Melo A, Duarte GB. Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach. Int J Equity Health 2021;20:183. [PMID: 34391416 DOI: 10.1186/s12939-021-01520-4] [Reference Citation Analysis]
142 Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37:e3377. [PMID: 32588943 DOI: 10.1002/dmrr.3377] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
143 Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scand J Immunol 2021;93:e13039. [PMID: 33710663 DOI: 10.1111/sji.13039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Tao Y, Tang LV, Hu Y. Treatments in the COVID-19 pandemic: an update on clinical trials. Expert Opin Emerg Drugs 2020;25:81-8. [PMID: 32447996 DOI: 10.1080/14728214.2020.1773431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
145 Grant JK, Vincent L, Ebner B, Hurwitz BE, Alcaide ML, Martinez C. Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations. J AIDS HIV Treat 2020;2:68-74. [PMID: 33748827 DOI: 10.33696/aids.2.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Phyu Khin P, Cha SH, Jun HS, Lee JH. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression. Med Hypotheses 2020;144:110186. [PMID: 33254506 DOI: 10.1016/j.mehy.2020.110186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
147 Shao MJ, Shang LX, Luo JY, Shi J, Zhao Y, Li XM, Yang YN. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. J Geriatr Cardiol 2020;17:224-8. [PMID: 32362922 DOI: 10.11909/j.issn.1671-5411.2020.04.009] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
148 Halvatsiotis P, Kotanidou A, Tzannis K, Jahaj E, Magira E, Theodorakopoulou M, Konstandopoulou G, Gkeka E, Pourzitaki C, Kapravelos N, Papoti S, Sileli M, Gogos C, Velissaris D, Markou N, Stefanatou E, Vlachogianni G, Aimoniotou E, Komnos A, Zafeiridis T, Koulouvaris P, Armaganidis A, Bamias A, Dimopoulos G. Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity. Diabetes Res Clin Pract 2020;166:108331. [PMID: 32682810 DOI: 10.1016/j.diabres.2020.108331] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
149 Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020;21:495-507. [PMID: 32643004 DOI: 10.1007/s11154-020-09569-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 39.0] [Reference Citation Analysis]
150 Sukkar SG, Bassetti M. Induction of ketosis as a potential therapeutic option to limit hyperglycemia and prevent cytokine storm in COVID-19. Nutrition. 2020;79-80:110967. [PMID: 32942131 DOI: 10.1016/j.nut.2020.110967] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
151 Altonen BL, Arreglado TM, Leroux O, Murray-Ramcharan M, Engdahl R. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City. PLoS One 2020;15:e0243343. [PMID: 33315929 DOI: 10.1371/journal.pone.0243343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
152 Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, Bonacini R, Nitrosi A, Bonelli E, Canovi S, Colla R, Zerbini A, Massari M, Lattuada I, Ferrari AM, Giorgi Rossi P; Reggio Emilia COVID-19 Working Group. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol 2021. [PMID: 33978822 DOI: 10.1007/s00330-021-07993-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med 2020;14:713-6. [PMID: 32426991 DOI: 10.2217/bmm-2020-0201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
154 Siddamreddy S, Thotakura R, Dandu V, Kanuru S, Meegada S. Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction. Cureus 2020;12:e7782. [PMID: 32337148 DOI: 10.7759/cureus.7782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
155 Shenoy A, Ismaily M, Bajaj M. Diabetes and covid-19: a global health challenge. BMJ Open Diabetes Res Care 2020;8:e001450. [PMID: 32345580 DOI: 10.1136/bmjdrc-2020-001450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
156 Hussain A, do Vale Moreira NC. Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.). Diabetes Metab Syndr 2020;14:363. [PMID: 32325393 DOI: 10.1016/j.dsx.2020.04.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
157 Li B, Jin X, Zhang T, Zhao Y, Tian F, Li Y, Yang J, Zhao F, Li B. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS. Eur J Prev Cardiol 2020;27:1320-4. [PMID: 32423251 DOI: 10.1177/2047487320925218] [Reference Citation Analysis]
158 Yi Y, Xu Y, Jiang H, Wang J. Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure. Front Cardiovasc Med 2021;8:629958. [PMID: 33791346 DOI: 10.3389/fcvm.2021.629958] [Reference Citation Analysis]
159 Singh H, Kakkar AK, Chauhan P. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges. Expert Rev Anti Infect Ther 2020;18:997-1003. [PMID: 32552044 DOI: 10.1080/14787210.2020.1782190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
160 Kirby JJ, Shaikh S, Bryant DP, Ho AF, d'Etienne JP, Schrader CD, Wang H. A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019. J Clin Med Res 2021;13:237-44. [PMID: 34007362 DOI: 10.14740/jocmr4476] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Tadic M, Cuspidi C, Grassi G, Mancia G. COVID-19 and arterial hypertension: Hypothesis or evidence? J Clin Hypertens (Greenwich) 2020;22:1120-6. [PMID: 32627330 DOI: 10.1111/jch.13925] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
162 Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, Yu J, Yao J, Wu Q, Bao Z, Zhao W. SARS-CoV-2: characteristics and current advances in research. Virol J 2020;17:117. [PMID: 32727485 DOI: 10.1186/s12985-020-01369-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 28.0] [Reference Citation Analysis]
163 Belarte-Tornero LC, Valdivielso-Moré S, Vicente Elcano M, Solé-González E, Ruíz-Bustillo S, Calvo-Fernández A, Subinara I, Cabero P, Soler C, Cubero-Gallego H, Vaquerizo B, Farré N. Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection. J Clin Med 2021;10:323. [PMID: 33477268 DOI: 10.3390/jcm10020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Hussain A, do Vale Moreira NC. Clinical considerations for patients with diabetes in times of COVID-19 pandemic. Diabetes Metab Syndr 2020;14:451-3. [PMID: 32388324 DOI: 10.1016/j.dsx.2020.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
165 Sharma D, Rasmussen M, Han R, Whalin MK, Davis M, Kofke WA, Venkatraghvan L, Raychev R, Fraser JF. Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement From Society for Neuroscience in Anesthesiology & Critical Care (SNACC): Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section. J Neurosurg Anesthesiol 2020;32:193-201. [PMID: 32282614 DOI: 10.1097/ANA.0000000000000688] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 48.0] [Reference Citation Analysis]
166 Chowdhury TA. Diabetes and COVID-19: Diseases of racial, social and glucose intolerance. World J Diabetes 2021;12:198-205. [PMID: 33758642 DOI: 10.4239/wjd.v12.i3.198] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
167 Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0250602. [PMID: 33939733 DOI: 10.1371/journal.pone.0250602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
168 Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metabolism 2020;107:154217. [PMID: 32220611 DOI: 10.1016/j.metabol.2020.154217] [Cited by in Crossref: 71] [Cited by in F6Publishing: 50] [Article Influence: 71.0] [Reference Citation Analysis]
169 Wong LSY, Loo EXL, Kang AYH, Lau HX, Tambyah PA, Tham EH. Age-Related Differences in Immunological Responses to SARS-CoV-2. J Allergy Clin Immunol Pract 2020;8:3251-8. [PMID: 32861856 DOI: 10.1016/j.jaip.2020.08.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
170 Papazafiropoulou AK, Antonopoulos S. The COVID-19 pandemic and diabetes mellitus. Arch Med Sci Atheroscler Dis 2020;5:e200-5. [PMID: 32832721 DOI: 10.5114/amsad.2020.97435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
171 Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun 2021;22:141-60. [PMID: 34140652 DOI: 10.1038/s41435-021-00140-w] [Reference Citation Analysis]
172 Yang Y, Chen XFD, Chen Y, Xie H, Xie C, Ying L. The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22587. [PMID: 33126305 DOI: 10.1097/MD.0000000000022587] [Reference Citation Analysis]
173 Jillella DV, Janocko NJ, Nahab F, Benameur K, Greene JG, Wright WL, Obideen M, Rangaraju S. Ischemic stroke in COVID-19: An urgent need for early identification and management. PLoS One 2020;15:e0239443. [PMID: 32946512 DOI: 10.1371/journal.pone.0239443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
174 Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, Arredondo AM, Escobar A, Rojas-Villarraga A. SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression. Reumatol Clin (Engl Ed) 2021;17:408-19. [PMID: 34301385 DOI: 10.1016/j.reumae.2020.08.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Erbay G, Sanli A, Turel H, Yavuz U, Erdogan A, Karabakan M, Yaris M, Gultekin MH. Short-term effects of COVID-19 on semen parameters: A multicenter study of 69 cases. Andrology 2021;9:1060-5. [PMID: 33851521 DOI: 10.1111/andr.13019] [Reference Citation Analysis]
176 Tommasi M, Toro F, Arnò S, Carrieri A, Conte MM, Devastato MD, Picconi L, Sergi MR, Saggino A. Physical and Psychological Impact of the Phase One Lockdown for COVID-19 on Italians. Front Psychol 2020;11:563722. [PMID: 33391079 DOI: 10.3389/fpsyg.2020.563722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
177 Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One 2020;15:e0241955. [PMID: 33201896 DOI: 10.1371/journal.pone.0241955] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 71.0] [Reference Citation Analysis]
178 Liu Y, Lu R, Wang J, Cheng Q, Zhang R, Zhang S, Le Y, Wang H, Xiao W, Gao H, Zeng L, Hong T. Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19. BMC Endocr Disord 2021;21:56. [PMID: 33771154 DOI: 10.1186/s12902-021-00717-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Mansueto G, Niola M, Napoli C. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? Pathol Res Pract 2020;216:153086. [PMID: 32825954 DOI: 10.1016/j.prp.2020.153086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
180 Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF, Eagleton M, Dua A. Blood type and outcomes in patients with COVID-19. Ann Hematol 2020;99:2113-8. [PMID: 32656591 DOI: 10.1007/s00277-020-04169-1] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 98.0] [Reference Citation Analysis]
181 Gangitano E, Tozzi R, Gandini O, Watanabe M, Basciani S, Mariani S, Lenzi A, Gnessi L, Lubrano C. Ketogenic Diet as a Preventive and Supportive Care for COVID-19 Patients. Nutrients 2021;13:1004. [PMID: 33804603 DOI: 10.3390/nu13031004] [Reference Citation Analysis]
182 Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020;36:1068-80. [PMID: 32425328 DOI: 10.1016/j.cjca.2020.05.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 68.0] [Reference Citation Analysis]
183 Asokan I, Rabadia SV, Yang EH. The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population. Curr Oncol Rep 2020;22:60. [PMID: 32462289 DOI: 10.1007/s11912-020-00945-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
184 Jiang G, Cai Y, Yi X, Li Y, Lin Y, Li Q, Xu J, Ke M, Xue K. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study. J Med Virol 2020;92:2124-9. [PMID: 32396239 DOI: 10.1002/jmv.25998] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
185 Sabatino J, Ferrero P, Chessa M, Bianco F, Ciliberti P, Secinaro A, Oreto L, Avesani M, Bucciarelli V, Calcaterra G, Calabrò MP, Russo MG, Bassareo PP, Guccione P, Indolfi C, Di Salvo G. COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. J Clin Med 2020;9:E1774. [PMID: 32521643 DOI: 10.3390/jcm9061774] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
186 Laires PA, Dias S, Gama A, Moniz M, Pedro AR, Soares P, Aguiar P, Nunes C. The Association Between Chronic Disease and Serious COVID-19 Outcomes and Its Influence on Risk Perception: Survey Study and Database Analysis. JMIR Public Health Surveill 2021;7:e22794. [PMID: 33433397 DOI: 10.2196/22794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
187 Abootalebi S, Aertker BM, Andalibi MS, Asdaghi N, Aykac O, Azarpazhooh MR, Bahit MC, Barlinn K, Basri H, Shahripour RB, Bersano A, Biller J, Borhani-Haghighi A, Brown RD, Campbell BC, Cruz-Flores S, De Silva DA, Di Napoli M, Divani AA, Edgell RC, Fifi JT, Ghoreishi A, Hirano T, Hong KS, Hsu CY, Huang JF, Inoue M, Jagolino AL, Kapral M, Kee HF, Keser Z, Khatri R, Koga M, Krupinski J, Liebeskind DS, Liu L, Ma H, Maud A, McCullough LD, Meyer DM, Mifsud V, Morovatdar N, Nilanont Y, Oxley TJ, Özdemir AÖ, Pandian J, Pantoni L, Papamitsakis NIH, Parry-Jones A, Phan T, Rodriguez G, Romano JG, Sabaa-Ayoun Z, Saber H, Sasannezhad P, Saver JL, Scharf E, Shuaib A, Silver B, Singhal S, Smith CJ, Stranges S, Sylaja PN, Torbey M, Toyoda K, Tsivgoulis G, Wasay M, Yassi N, Yoshimoto T, Zamani B, Zand R. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE). J Stroke Cerebrovasc Dis 2020;29:104938. [PMID: 32807412 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104938] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
188 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 174] [Article Influence: 185.0] [Reference Citation Analysis]
189 George JA, Mayne ES. The Novel Coronavirus and Inflammation. Adv Exp Med Biol 2021;1321:127-38. [PMID: 33656719 DOI: 10.1007/978-3-030-59261-5_11] [Reference Citation Analysis]
190 Ferreira-Santos D, Maranhão P, Monteiro-Soares M; COVIDcids. Identifying common baseline clinical features of COVID-19: a scoping review. BMJ Open 2020;10:e041079. [PMID: 32938604 DOI: 10.1136/bmjopen-2020-041079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
191 Abdelhafiz AH, Emmerton D, Sinclair AJ. Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes. Int J Clin Pract 2021;75:e14112. [PMID: 33630378 DOI: 10.1111/ijcp.14112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Hasan SS, Kow CS, Hadi MA, Zaidi STR, Merchant HA. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs 2020;20:571-90. [PMID: 32918209 DOI: 10.1007/s40256-020-00439-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
193 Alsufyani HA, Docherty JR. The renin angiotensin aldosterone system and COVID-19. Saudi Pharm J 2020;28:977-84. [PMID: 32788834 DOI: 10.1016/j.jsps.2020.06.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
194 Elvira Arcellana A, Jimeno C. Challenges and Opportunities for Diabetes Care in the Philippines in the Time of the COVID-19 Pandemic. J ASEAN Fed Endocr Soc 2020;35:55-7. [PMID: 33442171 DOI: 10.15605/jafes.035.01.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Gupta MD, Girish MP, Yadav G, Shankar A, Yadav R. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications. Indian Heart J 2020;72:1-6. [PMID: 32423554 DOI: 10.1016/j.ihj.2020.03.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
196 Mozzini C, Cicco S, Setti A, Racanelli V, Vacca A, Calciano L, Pesce G, Girelli D. Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting. Curr Probl Cardiol 2021;46:100819. [PMID: 33631706 DOI: 10.1016/j.cpcardiol.2021.100819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Górnicka M, Drywień ME, Zielinska MA, Hamułka J. Dietary and Lifestyle Changes During COVID-19 and the Subsequent Lockdowns among Polish Adults: A Cross-Sectional Online Survey PLifeCOVID-19 Study. Nutrients 2020;12:E2324. [PMID: 32756458 DOI: 10.3390/nu12082324] [Cited by in Crossref: 90] [Cited by in F6Publishing: 61] [Article Influence: 90.0] [Reference Citation Analysis]
198 Kerneis M, Ferrante A, Guedeney P, Vicaut E, Montalescot G. Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis. Arch Cardiovasc Dis 2020;113:797-810. [PMID: 33199208 DOI: 10.1016/j.acvd.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Cordeanu EM, Duthil N, Severac F, Lambach H, Tousch J, Jambert L, Mirea C, Delatte A, Younes W, Frantz AS, Merdji H, Schini-Kerth V, Bilbault P, Ohlmann P, Andres E, Stephan D. Prognostic Value of Troponin Elevation in COVID-19 Hospitalized Patients. J Clin Med 2020;9:E4078. [PMID: 33348719 DOI: 10.3390/jcm9124078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
200 Bello B, Useh U. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity? Am J Health Promot 2021;35:720-9. [PMID: 33576237 DOI: 10.1177/0890117121990518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
201 Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med.  2020: 1-8. [PMID: 32838147 DOI: 10.1007/s42399-020-00363-4] [Cited by in Crossref: 202] [Cited by in F6Publishing: 149] [Article Influence: 202.0] [Reference Citation Analysis]
202 Rogero MM, Leão MC, Santana TM, Pimentel MVMB, Carlini GCG, da Silveira TFF, Gonçalves RC, Castro IA. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med 2020;156:190-9. [PMID: 32653511 DOI: 10.1016/j.freeradbiomed.2020.07.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 41.0] [Reference Citation Analysis]
203 Kiss P, Carcel C, Hockham C, Peters SAE. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes 2021;7:18-27. [PMID: 33151274 DOI: 10.1093/ehjqcco/qcaa084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
204 Comunian S, Dongo D, Milani C, Palestini P. Air Pollution and Covid-19: The Role of Particulate Matter in the Spread and Increase of Covid-19's Morbidity and Mortality. Int J Environ Res Public Health 2020;17:E4487. [PMID: 32580440 DOI: 10.3390/ijerph17124487] [Cited by in Crossref: 124] [Cited by in F6Publishing: 75] [Article Influence: 124.0] [Reference Citation Analysis]
205 Imdad K, Sahana M, Rana MJ, Haque I, Patel PP, Pramanik M. A district-level susceptibility and vulnerability assessment of the COVID-19 pandemic's footprint in India. Spat Spatiotemporal Epidemiol 2021;36:100390. [PMID: 33509422 DOI: 10.1016/j.sste.2020.100390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
206 Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect 2020;81:1-9. [PMID: 32315723 DOI: 10.1016/j.jinf.2020.04.011] [Cited by in Crossref: 106] [Cited by in F6Publishing: 71] [Article Influence: 106.0] [Reference Citation Analysis]
207 Cordeanu EM, Jambert L, Severac F, Lambach H, Tousch J, Heitz M, Mirea C, Hamadé A, Younes W, Frantz AS, Merdji H, Schini-Kerth V, Bilbault P, Meziani F, Ohlmann P, Andres E, Stephan D. Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors. J Clin Med 2020;9:E3472. [PMID: 33126565 DOI: 10.3390/jcm9113472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Papadokostaki E, Tentolouris N, Liberopoulos E. COVID-19 and diabetes: What does the clinician need to know? Prim Care Diabetes 2020;14:558-63. [PMID: 32654982 DOI: 10.1016/j.pcd.2020.06.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
209 Silverio R, Gonçalves DC, Andrade MF, Seelaender M. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link? Adv Nutr 2021;12:682-92. [PMID: 32975565 DOI: 10.1093/advances/nmaa125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
210 Bertoncelli D, Guidarini M, Della Greca A, Ratti C, Falcinella F, Iovane B, Dutto ML, Caffarelli C, Tchana B. COVID19: potential cardiovascular issues in pediatric patients. Acta Biomed 2020;91:177-83. [PMID: 32420942 DOI: 10.23750/abm.v91i2.9655] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
211 Scudiero F, Parodi G. Dual antiplatelet therapy in patients with acute coronary syndrome during the coronavirus disease of 2019 pandemia: the right choice at the right time. J Cardiovasc Med (Hagerstown) 2020;21:535-7. [PMID: 32628420 DOI: 10.2459/JCM.0000000000001028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
212 Rhee EJ, Kim JH, Moon SJ, Lee WY. Encountering COVID-19 as Endocrinologists. Endocrinol Metab (Seoul) 2020;35:197-205. [PMID: 32372573 DOI: 10.3803/EnM.2020.35.2.197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
213 Mei J, Hu W, Chen Q, Li C, Chen Z, Fan Y, Tian S, Zhang Z, Li B, Ye Q, Yue J, Wang QL. Development and external validation of a COVID-19 mortality risk prediction algorithm: a multicentre retrospective cohort study. BMJ Open 2020;10:e044028. [PMID: 33361083 DOI: 10.1136/bmjopen-2020-044028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
214 Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:823-833. [PMID: 32798471 DOI: 10.1016/s2213-8587(20)30271-0] [Cited by in Crossref: 225] [Cited by in F6Publishing: 124] [Article Influence: 225.0] [Reference Citation Analysis]
215 Savoia C, Volpe M, Kreutz R. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Circ Res 2021;128:1062-79. [PMID: 33793331 DOI: 10.1161/CIRCRESAHA.121.318054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
216 Valverde-López F, Tendero-Peinado C, Lecuona-Muñoz M, Heredia-Carrasco C, Abellán-Alfocea P, Ortega-Suazo EJ, Martín-Rodríguez MDM, Sánchez-Capilla AD, Sotorrío-Simó V, Jiménez-Rosales R, Redondo-Cerezo E. A Gastroenterologist' clinical experience in COVID 19 and in-hospital mortality and length of stay analysis. Postgrad Med 2021;133:592-8. [PMID: 34171981 DOI: 10.1080/00325481.2021.1949200] [Reference Citation Analysis]
217 Guven G, Ince C, Topeli A, Caliskan K. Cardio-Pulmonary-Renal Consequences of Severe COVID-19. Cardiorenal Med 2021;11:133-9. [PMID: 34082420 DOI: 10.1159/000516740] [Reference Citation Analysis]
218 El Rhalete A, Rhazi I, Bensaid A, Zaid I, Bkiyer H, Ismaili N, Elouafi N, Housni B. Cardiovascular injuries during COVID-19 infection: A PROCESS-compliant case series from the Eastern Morocco. Ann Med Surg (Lond) 2021;65:102309. [PMID: 33898022 DOI: 10.1016/j.amsu.2021.102309] [Reference Citation Analysis]
219 Orlando V, Coscioni E, Guarino I, Mucherino S, Perrella A, Trama U, Limongelli G, Menditto E. Drug-utilisation profiles and COVID-19. Sci Rep 2021;11:8913. [PMID: 33903671 DOI: 10.1038/s41598-021-88398-y] [Reference Citation Analysis]
220 Armanini MP, McMahon SB, Sutherland J, Shelton DL, Phillips HS. Truncated and catalytic isoforms of trkB are co-expressed in neurons of rat and mouse CNS. Eur J Neurosci. 1995;7:1403-1409. [PMID: 7582115 DOI: 10.4239/wjd.v11.i10.468] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
221 Petrovic V, Radenkovic D, Radenkovic G, Djordjevic V, Banach M. Pathophysiology of Cardiovascular Complications in COVID-19. Front Physiol 2020;11:575600. [PMID: 33162899 DOI: 10.3389/fphys.2020.575600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
222 [DOI: 10.1101/2020.05.06.20093260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Hayden MR. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. J Int Med Res. 2020;48:300060520939746. [PMID: 32722979 DOI: 10.1177/0300060520939746] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
224 Khan S, Tombuloglu H, Hassanein SE, Rehman S, Bozkurt A, Cevik E, Abdel-Ghany S, Nabi G, Ali A, Sabit H. Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective. Eur J Pharmacol 2020;886:173447. [PMID: 32763302 DOI: 10.1016/j.ejphar.2020.173447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
225 Pooladanda V, Thatikonda S, Godugu C. The current understanding and potential therapeutic options to combat COVID-19. Life Sci 2020;254:117765. [PMID: 32437797 DOI: 10.1016/j.lfs.2020.117765] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 38.0] [Reference Citation Analysis]
226 Chang WT, Toh HS, Liao CT, Yu WL. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci 2021;361:14-22. [PMID: 33187633 DOI: 10.1016/j.amjms.2020.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
227 Gamsızkan Z, Sungur MA, Erdemir G. How do older age, gender and risk groups affect protective behaviours and mental health in the COVID-19 pandemic? Int J Clin Pract 2021;75:e14150. [PMID: 33720469 DOI: 10.1111/ijcp.14150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med (Lausanne) 2020;7:526. [PMID: 32903492 DOI: 10.3389/fmed.2020.00526] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 42.0] [Reference Citation Analysis]
229 Grippo F, Grande E, Maraschini A, Navarra S, Pappagallo M, Marchetti S, Crialesi R, Frova L, Orsi C, Simeoni S, Carinci A, Loreto G, Donfrancesco C, Lo Noce C, Palmieri L, Andrianou X, Urdiales AM, Onder G, Minelli G; Italian National Institute of Health COVID-19 Mortality Group. Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates. Front Med (Lausanne) 2021;8:645543. [PMID: 33829025 DOI: 10.3389/fmed.2021.645543] [Reference Citation Analysis]
230 Sliwa K, Singh K, Raspail L, Ojji D, Lam CSP, Thienemann F, Ge J, Banerjee A, Newby LK, Ribeiro ALP, Gidding S, Pinto F, Perel P, Prabhakaran D. The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. Glob Heart 2021;16:22. [PMID: 34040935 DOI: 10.5334/gh.950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Koçak G, Ergul Y, Nişli K, Hatemi AC, Tutar E, Tokel NK, Celebi A. Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery. Anatol J Cardiol 2020;24:13-8. [PMID: 32628134 DOI: 10.14744/AnatolJCardiol.2020.36559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Pan Y, Gao F, Zhao S, Han J, Chen F. Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection. Clin Exp Pharmacol Physiol 2021;48:637-50. [PMID: 33565127 DOI: 10.1111/1440-1681.13483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R, Baldanti F, Paolucci S, Pelenghi S, Iotti GA, Mojoli F, Arbustini E. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020;22:911-5. [PMID: 32275347 DOI: 10.1002/ejhf.1828] [Cited by in Crossref: 428] [Cited by in F6Publishing: 368] [Article Influence: 428.0] [Reference Citation Analysis]
234 Vas P, Hopkins D, Feher M, Rubino F, B Whyte M. Diabetes, obesity and COVID-19: A complex interplay. Diabetes Obes Metab 2020;22:1892-6. [PMID: 32627299 DOI: 10.1111/dom.14134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
235 Colombier S, Mahendiran T, Niclauss L, Kirsch M. Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report. Eur Heart J Case Rep 2021;5:ytaa475. [PMID: 33542974 DOI: 10.1093/ehjcr/ytaa475] [Reference Citation Analysis]
236 Sinclair JE, Zhu Y, Xu G, Ma W, Shi H, Ma KL, Cao CF, Kong LX, Wan KQ, Liao J, Wang HQ, Arentz M, Redd MA, Gallo LA, Short KR. A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection. iScience 2021;24:102264. [PMID: 33688629 DOI: 10.1016/j.isci.2021.102264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Verma AK, Beg MMA, Bhatt D, Dev K, Alsahli MA, Rahmani AH, Goyal Y. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic. Diabetes Metab Syndr Obes 2021;14:3131-46. [PMID: 34262317 DOI: 10.2147/DMSO.S285614] [Reference Citation Analysis]
238 Zaidel EJ, Forsyth CJ, Novick G, Marcus R, Ribeiro ALP, Pinazo MJ, Morillo CA, Echeverría LE, Shikanai-Yasuda MA, Buekens P, Perel P, Meymandi SK, Ralston K, Pinto F, Sosa-Estani S. COVID-19: Implications for People with Chagas Disease. Glob Heart 2020;15:69. [PMID: 33150134 DOI: 10.5334/gh.891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
239 Weikert T, Rapaka S, Grbic S, Re T, Chaganti S, Winkel DJ, Anastasopoulos C, Niemann T, Wiggli BJ, Bremerich J, Twerenbold R, Sommer G, Comaniciu D, Sauter AW. Prediction of Patient Management in COVID-19 Using Deep Learning-Based Fully Automated Extraction of Cardiothoracic CT Metrics and Laboratory Findings. Korean J Radiol 2021;22:994-1004. [PMID: 33686818 DOI: 10.3348/kjr.2020.0994] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Sharif N, Ahmed SN, Opu RR, Tani MR, Dewan D, Daullah MU, Shanto RI, Parvez AK, Talukder AA, Dey SK. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh. Diabetes Metab Syndr 2021;15:1009-16. [PMID: 33993046 DOI: 10.1016/j.dsx.2021.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
241 Saavedra JM. COVID-19, Angiotensin Receptor Blockers, and the Brain. Cell Mol Neurobiol 2020;40:667-74. [PMID: 32385549 DOI: 10.1007/s10571-020-00861-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
242 Sattar Y, Connerney M, Ullah W, Rauf H, Mamtani S, Luddington S, Alraies MC. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink. Cardiol Res 2020;11:196-9. [PMID: 32494330 DOI: 10.14740/cr1074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 [DOI: 10.1101/2020.06.23.167072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Chung SM, Lee YY, Ha E, Yoon JS, Won KC, Lee HW, Hur J, Hong KS, Jang JG, Jin HJ, Choi EY, Shin KC, Chung JH, Lee KH, Ahn JH, Moon JS. The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study. Diabetes Metab J 2020;44:405-13. [PMID: 32602272 DOI: 10.4093/dmj.2020.0105] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 29.0] [Reference Citation Analysis]
245 Shafi AMA, Atieh AE, Harky A, Sheikh AM, Awad WI. Impact of COVID-19 on cardiac surgical training: Our experience in the United Kingdom. J Card Surg 2020;35:1954-7. [PMID: 32557905 DOI: 10.1111/jocs.14693] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
246 Russell FM, Wang A, Ehrman RR, Jacobs J, Croft A, Larsen C. Risk factors associated with hospital admission in COVID-19 patients initially admitted to an observation unit. Am J Emerg Med 2021;46:339-43. [PMID: 33067060 DOI: 10.1016/j.ajem.2020.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
247 Peric S, Stulnig TM. Diabetes and COVID-19 : Disease-Management-People. Wien Klin Wochenschr 2020;132:356-61. [PMID: 32435867 DOI: 10.1007/s00508-020-01672-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
248 Diaz T, Trachtenberg BH, Abraham SJK, KosagiSharaf R, Durant-Archibold AA. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19. Front Cardiovasc Med 2020;7:562708. [PMID: 33330639 DOI: 10.3389/fcvm.2020.562708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
249 Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes Metab Syndr 2020;14:1109-20. [PMID: 32659694 DOI: 10.1016/j.dsx.2020.06.070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
250 Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020;65:533-46. [PMID: 32451563 DOI: 10.1007/s00038-020-01390-7] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 91.0] [Reference Citation Analysis]
251 Gustafson D, Raju S, Wu R, Ching C, Veitch S, Rathnakumar K, Boudreau E, Howe KL, Fish JE. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler Thromb Vasc Biol 2020;40:1818-29. [PMID: 32510978 DOI: 10.1161/ATVBAHA.120.314558] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 33.0] [Reference Citation Analysis]
252 Iqubal A, Iqubal MK, Hoda F, Najmi AK, Haque SE. COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention. Expert Rev Anti Infect Ther 2021;19:1083-92. [PMID: 33618607 DOI: 10.1080/14787210.2021.1893692] [Reference Citation Analysis]
253 Iacopi E, Pieruzzi L, Goretti C, Piaggesi A. I fear COVID but diabetic foot (DF) is worse: a survey on patients' perception of a telemedicine service for DF during lockdown. Acta Diabetol 2021;58:587-93. [PMID: 33439330 DOI: 10.1007/s00592-020-01653-y] [Reference Citation Analysis]
254 Tadic M, Cuspidi C, Mancia G, Dell'Oro R, Grassi G. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Pharmacol Res 2020;158:104906. [PMID: 32461198 DOI: 10.1016/j.phrs.2020.104906] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
255 Adam S, Zahra SA, Chor CYT, Khare Y, Harky A. COVID-19 pandemic and its impact on service provision: A cardiology prospect. Acta Cardiologica. [DOI: 10.1080/00015385.2020.1787636] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
256 Iqbal A, Greig M, Arshad MF, Julian TH, Ee Tan S, Elliott J. Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021;178:108955. [PMID: 34273452 DOI: 10.1016/j.diabres.2021.108955] [Reference Citation Analysis]
257 Patti G, Lio V, Cavallari I, Gragnano F, Riva L, Calabrò P, Di Pasquale G, Pengo V, Rubboli A; Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology. Am J Cardiovasc Drugs 2020;20:559-70. [PMID: 33145698 DOI: 10.1007/s40256-020-00446-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
258 Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020;288:192-206. [PMID: 32348588 DOI: 10.1111/joim.13091] [Cited by in Crossref: 375] [Cited by in F6Publishing: 266] [Article Influence: 375.0] [Reference Citation Analysis]
259 Nunes BP, Souza ASS, Nogueira J, Andrade FB, Thumé E, Teixeira DSDC, Lima-Costa MF, Facchini LA, Batista SR. Multimorbidity and population at risk for severe COVID-19 in the Brazilian Longitudinal Study of Aging. Cad Saude Publica 2020;36:e00129620. [PMID: 33237250 DOI: 10.1590/0102-311X00129620] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
260 Chua PEY, Shah SU, Gui H, Koh J, Somani J, Pang J. Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: a systematic review and meta-analysis of observational studies. J Investig Med 2021:jim-2021-001858. [PMID: 34135068 DOI: 10.1136/jim-2021-001858] [Reference Citation Analysis]
261 Elkahloun AG, Saavedra JM. Candesartan could ameliorate the COVID-19 cytokine storm. Biomed Pharmacother 2020;131:110653. [PMID: 32942152 DOI: 10.1016/j.biopha.2020.110653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
262 Chao LC, Vidmar AP, Georgia S. Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic. Diabetes Care 2021:dc202733. [PMID: 33905347 DOI: 10.2337/dc20-2733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, Bockey A, Vanella P, Krause G, Lange B. Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis. Syst Rev 2021;10:194. [PMID: 34193261 DOI: 10.1186/s13643-021-01732-3] [Reference Citation Analysis]
264 Pinna G, Sanfilippo L, Bassareo PP, Fanos V, Marcialis MA. COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review. Curr Pediatr Rev 2021;17:38-44. [PMID: 33183207 DOI: 10.2174/1573396316666201112093920] [Reference Citation Analysis]
265 Salimi S, Hamlyn JM. COVID-19 and Crosstalk With the Hallmarks of Aging. J Gerontol A Biol Sci Med Sci 2020;75:e34-41. [PMID: 32544216 DOI: 10.1093/gerona/glaa149] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 32.0] [Reference Citation Analysis]
266 Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol 2021;36:234-40. [PMID: 33394709 DOI: 10.1097/HCO.0000000000000832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
267 Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst 2021;113:513-22. [PMID: 33179744 DOI: 10.1093/jnci/djaa177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
268 Ye T, Xu R, Yu W, Chen Z, Guo Y, Li S. Vulnerability and Burden of All-Cause Mortality Associated with Particulate Air Pollution during COVID-19 Pandemic: A Nationwide Observed Study in Italy. Toxics 2021;9:56. [PMID: 33804264 DOI: 10.3390/toxics9030056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, Mocco J, Majidi S, Yeckley J, Aggarwal A, Lefton D, Doshi AH. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke. AJNR Am J Neuroradiol 2020;41:1361-4. [PMID: 32586968 DOI: 10.3174/ajnr.A6650] [Cited by in Crossref: 62] [Cited by in F6Publishing: 29] [Article Influence: 62.0] [Reference Citation Analysis]
270 [DOI: 10.1101/2020.06.17.20134007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Jaly I, Iyengar K, Bahl S, Hughes T, Vaishya R. Redefining diabetic foot disease management service during COVID-19 pandemic. Diabetes Metab Syndr 2020;14:833-8. [PMID: 32540738 DOI: 10.1016/j.dsx.2020.06.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 32.0] [Reference Citation Analysis]
272 Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): New treatment option against COVID-19. Food Sci Nutr 2020;8:5215-27. [PMID: 33133525 DOI: 10.1002/fsn3.1858] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 23.0] [Reference Citation Analysis]
273 Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H. Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits. Nutrients 2020;12:E1549. [PMID: 32466598 DOI: 10.3390/nu12061549] [Cited by in Crossref: 94] [Cited by in F6Publishing: 62] [Article Influence: 94.0] [Reference Citation Analysis]
274 Wu L, O'Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochem Pharmacol. 2020;178:114114. [PMID: 32579957 DOI: 10.1016/j.bcp.2020.114114] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 33.0] [Reference Citation Analysis]
275 Ronderos Botero DM, Omar AMS, Sun HK, Mantri N, Fortuzi K, Choi Y, Adrish M, Nicu M, Bella JN, Chilimuri S. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes. Arterioscler Thromb Vasc Biol 2020;40:2764-75. [PMID: 32907371 DOI: 10.1161/ATVBAHA.120.314845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
276 Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology 2020;:1-12. [PMID: 33296901 DOI: 10.1159/000512592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 24.0] [Reference Citation Analysis]
277 Toulkeridis T, Seqqat R, Torres Arias M, Salazar-Martinez R, Ortiz-Prado E, Chunga S, Vizuete K, Heredia-R M, Debut A. Volcanic Ash as a Precursor for SARS-CoV-2 Infection Among Susceptible Populations in Ecuador: A Satellite Imaging and Excess Mortality-Based Analysis. Disaster Med Public Health Prep 2021;:1-13. [PMID: 34006342 DOI: 10.1017/dmp.2021.154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Leslie-Mazwi TM, Fargen KM, Levitt M, Derdeyn CP, Feske SK, Patel AB, Hirsch JA. Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 Pandemic. AJNR Am J Neuroradiol 2020;41:1136-41. [PMID: 32439650 DOI: 10.3174/ajnr.A6606] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
279 Haddad C, Bou Malhab S, Sacre H, Salameh P. Smoking and COVID-19: A Scoping Review. Tob Use Insights 2021;14:1179173X21994612. [PMID: 33642886 DOI: 10.1177/1179173X21994612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
280 Rowland B, Kunadian V. Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic. Heart 2020;106:1296-301. [PMID: 32444504 DOI: 10.1136/heartjnl-2020-317011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
281 Capaccione KM, Leb JS, D'souza B, Utukuri P, Salvatore MM. Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature. Clin Imaging 2021;72:178-82. [PMID: 33296828 DOI: 10.1016/j.clinimag.2020.11.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
282 Benyounes N, Van Der Vynckt C, Tibi S, Iglesias A, Salomon L, Gout O, Tibi T. Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change. Cardiol Res Pract 2020;2020:4348598. [PMID: 32963823 DOI: 10.1155/2020/4348598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
283 O'Neil A, Nicholls SJ, Redfern J, Brown A, Hare DL. Mental Health and Psychosocial Challenges in the COVID-19 Pandemic: Food for Thought for Cardiovascular Health Care Professionals.Heart Lung Circ. 2020;29:960-963. [PMID: 32561126 DOI: 10.1016/j.hlc.2020.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
284 Rowaiye AB, Onuh OA, Oli AN, Okpalefe OA, Oni S, Nwankwo EJ. The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction. Pan Afr Med J 2020;36:188. [PMID: 32952832 DOI: 10.11604/pamj.2020.36.188.23476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Rivera-Hernandez P, Nair J, Islam S, Davidson L, Chang A, Elberson V. Coronavirus Disease 2019 in a Premature Infant: Vertical Transmission and Antibody Response or Lack Thereof. AJP Rep 2020;10:e224-7. [PMID: 33094009 DOI: 10.1055/s-0040-1715176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
286 [DOI: 10.1101/2020.04.27.20081794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
287 Dalla Volta A, Valcamonico F, Zamboni S, Ferrari VD, Grisanti S, Simeone C, Berruti A. Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? Minerva Urol Nefrol 2020;72:778-9. [PMID: 33016032 DOI: 10.23736/S0393-2249.20.04021-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
288 Romeyke T, Noehammer E, Stummer H. COVID-19 Patient with Severe Comorbidity in Multimodal Acute Care Setting with Non-Invasive Medical Ventilation: A Clinical Outcome Report. Clin Pract 2021;11:81-91. [PMID: 33546107 DOI: 10.3390/clinpract11010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
289 Munjal M, Das S, Chatterjee N, Setra AE, Govil D. Systemic Involvement of Novel Coronavirus (COVID-19): A Review of Literature. Indian J Crit Care Med 2020;24:565-9. [PMID: 32963441 DOI: 10.5005/jp-journals-10071-23498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
290 Golemi Minga I, Golemi L, Tafur A, Pursnani A. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease. Cardiol Rev 2020;28:163-76. [PMID: 32427637 DOI: 10.1097/CRD.0000000000000317] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
291 Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, Yang L, Wei Q, Wang H, Li H, Zheng J, Sun H, Xia W, Liu G, Zhong X, Qiu K, Li Y, Wang H, Wang Y, Song X, Liu H, Xiong S, Liu Y, Cui Z, Hu Y, Chen L, Pan A, Zeng T. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019. Front Endocrinol (Lausanne) 2020;11:525. [PMID: 32754119 DOI: 10.3389/fendo.2020.00525] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
292 Hoogenes B, Querée M, Townson A, Willms R, Eng JJ. COVID-19 and Spinal Cord Injury: Clinical Presentation, Clinical Course, and Clinical Outcomes: A Rapid Systematic Review. J Neurotrauma 2021;38:1242-50. [PMID: 33502924 DOI: 10.1089/neu.2020.7461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Scheen AJ, Marre M, Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes Metab 2020;46:265-71. [PMID: 32447101 DOI: 10.1016/j.diabet.2020.05.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 52.0] [Reference Citation Analysis]
294 Mascarello KC, Vieira ACBC, Souza ASS, Marcarini WD, Barauna VG, Maciel ELN. COVID-19 hospitalization and death and relationship with social determinants of health and morbidities in Espírito Santo State, Brazil: a cross-sectional study. Epidemiol Serv Saude 2021;30:e2020919. [PMID: 34287551 DOI: 10.1590/S1679-49742021000300004] [Reference Citation Analysis]
295 Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:355-6. [PMID: 32475769 DOI: 10.1016/j.endinu.2020.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
296 Ortiz-Hernández L, Pérez-Sastré MA. [Social inequalities in the progression of COVID-19 in the Mexican population]. Rev Panam Salud Publica 2020;44:e106. [PMID: 32983234 DOI: 10.26633/RPSP.2020.106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
297 Riederer P, Ter Meulen V. Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses. J Neural Transm (Vienna) 2020;127:1217-28. [PMID: 32725545 DOI: 10.1007/s00702-020-02230-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
298 Yang Y, Zhong W, Tian Y, Xie C, Fu X, Zhou H. The effect of diabetes on mortality of COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20913. [PMID: 32629686 DOI: 10.1097/MD.0000000000020913] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Kang J, Chen Y, Zhao Y, Zhang C. Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic. Prim Care Diabetes 2021;15:417-23. [PMID: 33422431 DOI: 10.1016/j.pcd.2020.12.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Fraticelli L, Freyssenge J, Claustre C, Martinez M, Redjaline A, Serre P, Bochaton T, El Khoury C. Estimating the Proportion of COVID-19 Contacts Among Households Based on Individuals With Myocardial Infarction History: Cross-sectional Telephone Survey. JMIR Form Res 2021;5:e26955. [PMID: 33855968 DOI: 10.2196/26955] [Reference Citation Analysis]
301 Semiz S, Serdarevic F. Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?Front Nutr. 2020;7:581680. [PMID: 33123550 DOI: 10.3389/fnut.2020.581680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Liu D, Zhang T, Wang Y, Xia L. The Centrality of Obesity in the Course of Severe COVID-19. Front Endocrinol (Lausanne) 2021;12:620566. [PMID: 33776917 DOI: 10.3389/fendo.2021.620566] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Coraggio L, Sterpetti S, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Agrò FE, Rocco M, Pugliese F, Mastroianni CM, Buzzetti R; CoViDiab Study group. Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract 2020;169:108454. [PMID: 32971157 DOI: 10.1016/j.diabres.2020.108454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
304 Sacks LJ, Pham CT, Fleming N, Neoh SL, Ekinci EI. Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic. Diabetes Res Clin Pract 2020;166:108296. [PMID: 32623041 DOI: 10.1016/j.diabres.2020.108296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
305 Majeed J, Ajmera P, Goyal RK. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement. Diabetes Res Clin Pract 2020;167:108349. [PMID: 32712124 DOI: 10.1016/j.diabres.2020.108349] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
306 Fraser JF, Arthur AS, Chen M, Levitt M, Mocco J, Albuquerque FC, Ansari SA, Dabus G, Jayaraman MV, Mack WJ, Milburn J, Mokin M, Narayanan S, Puri AS, Siddiqui AH, Tsai JP, Klucznik RP. Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of COVID-19. J NeuroIntervent Surg 2020;12:539-41. [DOI: 10.1136/neurintsurg-2020-016098] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 61.0] [Reference Citation Analysis]
307 Rahmani-Kukia N, Abbasi A. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Front Endocrinol (Lausanne) 2021;12:576412. [PMID: 33746897 DOI: 10.3389/fendo.2021.576412] [Reference Citation Analysis]
308 [DOI: 10.1101/2020.03.24.20041020] [Cited by in Crossref: 76] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
309 Bao Y, Lin SY, Cheng ZH, Xia J, Sun YP, Zhao Q, Liu GJ. Clinical Features of COVID-19 in a Young Man with Massive Cerebral Hemorrhage-Case Report. SN Compr Clin Med 2020;:1-7. [PMID: 32838132 DOI: 10.1007/s42399-020-00315-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
310 Parlakpinar H, Gunata M. SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments. Cell Biochem Funct 2021;39:10-28. [PMID: 32992409 DOI: 10.1002/cbf.3591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
311 Voulalas G, Tsui J, Candilio L, Baker D. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association? Clin Med Insights Cardiol 2021;15:11795468211010705. [PMID: 34035654 DOI: 10.1177/11795468211010705] [Reference Citation Analysis]
312 Núñez-Gil IJ, Fernández-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Muñoz VM, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas MC, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejía AF, Raposeiras-Roubin S, D'Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-Pérez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Underlying heart diseases and acute COVID-19 outcomes. Cardiol J 2021;28:202-14. [PMID: 33346365 DOI: 10.5603/CJ.a2020.0183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
313 Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep 2020;14:134. [PMID: 32838801 DOI: 10.1186/s13256-020-02461-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
314 Capone V, Cuomo V, Esposito R, Canonico ME, Ilardi F, Prastaro M, Esposito G, Santoro C. Epidemiology, prognosis, and clinical manifestation of cardiovascular disease in COVID-19. Expert Rev Cardiovasc Ther 2020;18:531-9. [PMID: 32672482 DOI: 10.1080/14779072.2020.1797491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
315 Liu Y, Wang K, Massoud TF, Paulmurugan R. SARS-CoV-2 Vaccine Development: An Overview and Perspectives. ACS Pharmacol Transl Sci 2020;3:844-58. [PMID: 33062951 DOI: 10.1021/acsptsci.0c00109] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
316 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 29.0] [Reference Citation Analysis]
317 Sönmez S, Apostolopoulos Y, Lemke MK, Hsieh YJ. Understanding the effects of COVID-19 on the health and safety of immigrant hospitality workers in the United States. Tour Manag Perspect 2020;35:100717. [PMID: 32834958 DOI: 10.1016/j.tmp.2020.100717] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 31.0] [Reference Citation Analysis]
318 Zylla MM, Merle U, Vey JA, Korosoglou G, Hofmann E, Müller M, Herth F, Schmidt W, Blessing E, Göggelmann C, Weidner N, Fiedler MO, Weigand MA, Kälble F, Morath C, Leiner J, Kieser M, Katus HA, Thomas D. Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19. J Clin Med 2021;10:E133. [PMID: 33401735 DOI: 10.3390/jcm10010133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
319 Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, Vemuri R. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Microorganisms 2021;9:1211. [PMID: 34205044 DOI: 10.3390/microorganisms9061211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, Sharma M, Jain A, Warikoo V. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.Diabetes Metab Syndr. 2020;14:1017-1025. [PMID: 32634716 DOI: 10.1016/j.dsx.2020.06.064] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 51.0] [Reference Citation Analysis]
321 O'Sullivan P, Younger J, Van Pelt N, O'Malley S, Lenturut-Katal D, Hirschfeld CB, Vitola JV, Cerci R, Williams MC, Shaw LJ, Raggi P, Villines TC, Dorbala S, Choi AD, Cohen Y, Goebel B, Malkovskiy E, Randazzo M, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ, Better N; INCAPS COVID Investigators Group. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID). Heart Lung Circ 2021;30:1477-86. [PMID: 34053885 DOI: 10.1016/j.hlc.2021.04.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. BMC Infect Dis 2021;21:113. [PMID: 33494706 DOI: 10.1186/s12879-021-05814-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
323 Kostova D, Richter P, Van Vliet G, Mahar M, Moolenaar RL. The Role of Noncommunicable Diseases in the Pursuit of Global Health Security. Health Secur 2021;19:288-301. [PMID: 33961498 DOI: 10.1089/hs.2020.0121] [Reference Citation Analysis]
324 Russo V, Bottino R, Carbone A, Rago A, Papa AA, Golino P, Nigro G. COVID-19 and Heart: From Clinical Features to Pharmacological Implications. J Clin Med 2020;9:E1944. [PMID: 32580344 DOI: 10.3390/jcm9061944] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
325 Jin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) 2021;12:602735. [PMID: 33995267 DOI: 10.3389/fendo.2021.602735] [Reference Citation Analysis]
326 Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic. Cardiovasc Drugs Ther 2021. [PMID: 34328581 DOI: 10.1007/s10557-021-07217-8] [Reference Citation Analysis]
327 Melo P, Barbosa JM, Jardim L, Carrilho E, Portugal J. COVID-19 Management in Clinical Dental Care. Part I: Epidemiology, Public Health Implications, and Risk Assessment. Int Dent J 2021;71:251-62. [PMID: 33879353 DOI: 10.1016/j.identj.2021.01.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Seecheran R, Narayansingh R, Giddings S, Rampaul M, Furlonge K, Abdool K, Bhagwandass N, Seecheran NA. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection. J Investig Med High Impact Case Rep 2020;8:2324709620925571. [PMID: 32370558 DOI: 10.1177/2324709620925571] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
329 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021;12:1026-41. [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Reference Citation Analysis]
330 Vallée A, Lecarpentier Y, Vallée JN. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front Immunol 2021;12:666693. [PMID: 33927728 DOI: 10.3389/fimmu.2021.666693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Pan J, Tian J, Xiong H, Liu Z, Yao Y, Wang Y, Zhu W, Wang Y, Wang W. Risk assessment and evaluation of China's policy to prevent COVID-19 cases imported by plane. PLoS Negl Trop Dis 2020;14:e0008908. [PMID: 33284804 DOI: 10.1371/journal.pntd.0008908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
332 Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19:345-357. [PMID: 32921216 DOI: 10.1080/14787210.2020.1822737] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
333 Altamimi H, Abid AR, Othman F, Patel A. Cardiovascular Manifestations of COVID-19. Heart Views 2020;21:171-86. [PMID: 33688409 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_150_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 McConachie D, McConachie N, White P, Crossley R, Izzath W. Mechanical thrombectomy for acute ischaemic stroke during the COVID-19 pandemic: changes to UK practice and lessons learned. Clin Radiol 2020;75:795.e7-795.e13. [PMID: 32682524 DOI: 10.1016/j.crad.2020.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
335 Taher N, Huda MS, Chowdhury TA. COVID-19 and diabetes: What have we learned so far? Clin Med (Lond) 2020;20:e87-90. [PMID: 32628128 DOI: 10.7861/clinmed.2020-0261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
336 Dioguardi M, Cazzolla AP, Arena C, Sovereto D, Caloro GA, Dioguardi A, Crincoli V, Laino L, Troiano G, Lo Muzio L. Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection. Pediatr Rep 2021;13:363-82. [PMID: 34287338 DOI: 10.3390/pediatric13030045] [Reference Citation Analysis]
337 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Eur J Clin Nutr 2021;75:1332-6. [PMID: 34163019 DOI: 10.1038/s41430-021-00961-y] [Reference Citation Analysis]
338 Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19. Diabetes Metab Syndr. 2020;14:2003-2006. [PMID: 33091758 DOI: 10.1016/j.dsx.2020.10.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
339 Jones J, Sullivan PS, Sanchez TH, Guest JL, Hall EW, Luisi N, Zlotorzynska M, Wilde G, Bradley H, Siegler AJ. Similarities and Differences in COVID-19 Awareness, Concern, and Symptoms by Race and Ethnicity in the United States: Cross-Sectional Survey. J Med Internet Res 2020;22:e20001. [PMID: 32614778 DOI: 10.2196/20001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 35.0] [Reference Citation Analysis]
340 Hamouche W, Bisserier M, Brojakowska A, Eskandari A, Fish K, Goukassian DA, Hadri L. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19. J Mol Cell Cardiol 2021;153:72-85. [PMID: 33373644 DOI: 10.1016/j.yjmcc.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
341 O'Hearn M, Liu J, Cudhea F, Micha R, Mozaffarian D. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis. J Am Heart Assoc 2021;10:e019259. [PMID: 33629868 DOI: 10.1161/JAHA.120.019259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
342 Yau O, Gin K, Luong C, Jue J, Abolmaesumi P, Tsang M, Nair P, Tsang TSM. Point-of-care ultrasound in the COVID-19 era: A scoping review. Echocardiography. 2021;38:329-342. [PMID: 33332638 DOI: 10.1111/echo.14951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
343 Davis GK, Adlan A, Majewski J, Ibrahim B. SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know. Clin Med (Lond) 2020:clinmed. [PMID: 32354733 DOI: 10.7861/clinmed.2020-0158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
344 Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142. [PMID: 32278764 DOI: 10.1016/j.diabres.2020.108142] [Cited by in Crossref: 266] [Cited by in F6Publishing: 195] [Article Influence: 266.0] [Reference Citation Analysis]
345 Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ. The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol 2020;11:1991. [PMID: 32903476 DOI: 10.3389/fimmu.2020.01991] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 23.0] [Reference Citation Analysis]
346 Naksuk N, Lazar S, Peeraphatdit TB. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care 2020;9:215-21. [PMID: 32372695 DOI: 10.1177/2048872620922784] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 65.0] [Reference Citation Analysis]
347 Subir R, Jagat J M, Kalyan K G. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19). Diabetes Metab Syndr 2020;14:1225-9. [PMID: 32683320 DOI: 10.1016/j.dsx.2020.07.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
348 Das AK, Mishra S, Saraswathy Gopalan S. Predicting CoVID-19 community mortality risk using machine learning and development of an online prognostic tool. PeerJ 2020;8:e10083. [PMID: 33062451 DOI: 10.7717/peerj.10083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
349 Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD. Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction. Front Cardiovasc Med 2020;7:598400. [PMID: 33195487 DOI: 10.3389/fcvm.2020.598400] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
350 He J, Zhang B, Zhou Q, Yang W, Xu J, Liu T, Zhang H, Wu Z, Li D, Zhou Q, Yan J, Zhang C, Qian H, Lu M, Zhou X. The prognostic value of myocardial injury in COVID-19 patients and associated characteristics. Immun Inflamm Dis 2021. [PMID: 34240818 DOI: 10.1002/iid3.484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Angelidi AM, Belanger MJ, Mantzoros CS. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next. Metabolism. 2020;107:154245. [PMID: 32320742 DOI: 10.1016/j.metabol.2020.154245] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 37.0] [Reference Citation Analysis]
352 Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity. WJD 2021;12:1550-62. [DOI: 10.4239/wjd.v12.i9.1550] [Reference Citation Analysis]
353 Guha S, Mukhopadhay S, Karak A, Choudhury B, Kapoor A, Yadav R. Managing ACS during COVID-19 infection: Do not follow the traditional route. Indian Heart J 2020;72:128-30. [PMID: 32534687 DOI: 10.1016/j.ihj.2020.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Abate SM, Mantefardo B, Basu B. Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis. Patient Saf Surg. 2020;14:37. [PMID: 33062056 DOI: 10.1186/s13037-020-00262-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
355 Suzuki YJ. The viral protein fragment theory of COVID-19 pathogenesis. Med Hypotheses 2020;144:110267. [PMID: 33254571 DOI: 10.1016/j.mehy.2020.110267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
356 Hassanein M, Alamoudi RM, Kallash MA, Aljohani NJ, Alfadhli EM, Tony LE, Khogeer GS, Alfadhly AF, Khater AE, Ahmedani MY, Buyukbese MA, Shaltout I, Belkhadir J, Hafidh K, Chowdhury TA, Hussein Z, Elbarbary NS. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey. Diabetes Res Clin Pract 2021;172:108626. [PMID: 33321160 DOI: 10.1016/j.diabres.2020.108626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
357 Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 2020;127:104354. [PMID: 32305882 DOI: 10.1016/j.jcv.2020.104354] [Cited by in Crossref: 140] [Cited by in F6Publishing: 107] [Article Influence: 140.0] [Reference Citation Analysis]
358 Ding Q, Shults NV, Harris BT, Suzuki YJ. Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer's disease brain. bioRxiv 2020:2020. [PMID: 33052346 DOI: 10.1101/2020.10.08.331157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
359 Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes 2020;12:895-908. [PMID: 32671936 DOI: 10.1111/1753-0407.13085] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 23.0] [Reference Citation Analysis]
360 Okpara IC, Oghagbon EK. Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities. Front Cardiovasc Med 2021;8:626115. [PMID: 33665211 DOI: 10.3389/fcvm.2021.626115] [Reference Citation Analysis]
361 Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020;. [PMID: 32331955 DOI: 10.1016/j.ajem.2020.04.052] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 65.0] [Reference Citation Analysis]
362 Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther 2021;35:411-25. [PMID: 32926272 DOI: 10.1007/s10557-020-07073-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
363 Sun ZH. Clinical outcomes of COVID-19 in elderly male patients. J Geriatr Cardiol 2020;17:243-5. [PMID: 32547606 DOI: 10.11909/j.issn.1671-5411.2020.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
364 Navlakha S, Morjaria S, Perez-Johnston R, Zhang A, Taur Y. Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning. BMC Infect Dis 2021;21:391. [PMID: 33941093 DOI: 10.1186/s12879-021-06038-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Angeli E, Dalto S, Marchese S, Setti L, Bonacina M, Galli F, Rulli E, Torri V, Monti C, Meroni R, Beretta GD, Castoldi M, Bombardieri E. Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome. Eur J Radiol 2021;137:109612. [PMID: 33662842 DOI: 10.1016/j.ejrad.2021.109612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
366 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
367 Lemke MK, Apostolopoulos Y, Sönmez S. Syndemic frameworks to understand the effects of COVID-19 on commercial driver stress, health, and safety. J Transp Health 2020;18:100877. [PMID: 32501420 DOI: 10.1016/j.jth.2020.100877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
368 He X, Wang L, Wang H, Xie Y, Yu Y, Sun J, Yan J, Du Y, Shen Y, Zeng H. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19. Sci Rep 2020;10:20452. [PMID: 33235220 DOI: 10.1038/s41598-020-77172-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
369 Hasani WSR, Ganapathy SS, Lin CZ, Rifin HM, Bahari MN, Ghazali MH, Lodz NA, Ramli MHT, Majid NLA, Ling MYJ, Yusoff MFM, Ahmad NA, Suleiman A, Yusoff AF, Balan V, Ngadiman S. Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia. Western Pac Surveill Response J 2021;12:46-52. [PMID: 34094624 DOI: 10.5365/wpsar.2020.11.3.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IRL, Contini AA, Ued FDV. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020;96:546-558. [PMID: 32768388 DOI: 10.1016/j.jped.2020.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
371 Pereira NL, Ahmad F, Byku M, Cummins NW, Morris AA, Owens A, Tuteja S, Cresci S. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine. Mayo Clin Proc 2021;96:446-63. [PMID: 33549263 DOI: 10.1016/j.mayocp.2020.11.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
372 Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, Vidán-Austiz MT, Formiga F, Ariza-Solé A, Martínez-Sellés M; Scientific societies of the authors. The contributing authors are members of the following scientific bodies. Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Rev Esp Cardiol (Engl Ed) 2020;73:569-76. [PMID: 32446793 DOI: 10.1016/j.rec.2020.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
373 Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Al-Zakwani I, Hannawi S. Kidney Dysfunction among COVID-19 Patients in the United Arab Emirates. Oman Med J 2021;36:e221. [PMID: 33585042 DOI: 10.5001/omj.2020.92] [Reference Citation Analysis]
374 Suzuki YJ, Nikolaienko SI, Dibrova VA, Dibrova YV, Vasylyk VM, Novikov MY, Shults NV, Gychka SG. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascul Pharmacol 2021;137:106823. [PMID: 33232769 DOI: 10.1016/j.vph.2020.106823] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
375 Bhansali S, Minocha P, Phoon C, Henry G, Chakravarti S, Ramirez M, Bhatla P. Cardiac involvement in a pediatric patient with COVID-19: Looking beyond the nonspecific global cardiac injury. Echocardiography 2020;37:1488-91. [PMID: 32770794 DOI: 10.1111/echo.14814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
376 Sheikhzadeh Hesari F, Hosseinzadeh SS, Asl Monadi Sardroud MA. Review of COVID-19 and male genital tract. Andrologia 2021;53:e13914. [PMID: 33236375 DOI: 10.1111/and.13914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
377 Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, Mohamed N, Lundon D, Dovey Z, Kyprianou N, Tewari AK. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Commun Biol 2020;3:374. [PMID: 32641750 DOI: 10.1038/s42003-020-1088-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 53.0] [Reference Citation Analysis]
378 Abi Nassif T, Fakhri G, Younis NK, Zareef R, Al Amin F, Bitar F, Arabi M. Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population. Can J Infect Dis Med Microbiol 2021;2021:5518979. [PMID: 34326911 DOI: 10.1155/2021/5518979] [Reference Citation Analysis]
379 Mansour S, Al Kindi A, Al-Said A, Al-Said A, Atkinson P. Sociodemographic determinants of COVID-19 incidence rates in Oman: Geospatial modelling using multiscale geographically weighted regression (MGWR). Sustain Cities Soc 2021;65:102627. [PMID: 33288993 DOI: 10.1016/j.scs.2020.102627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 17.0] [Reference Citation Analysis]
380 Gnoni M, Beas R, Vásquez-Garagatti R. Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction. Virusdisease 2021;:1-10. [PMID: 34104708 DOI: 10.1007/s13337-021-00703-5] [Reference Citation Analysis]
381 Ahrenfeldt LJ, Nielsen CR, Möller S, Christensen K, Lindahl-Jacobsen R. Burden and prevalence of risk factors for severe COVID-19 in the ageing European population - a SHARE-based analysis. Z Gesundh Wiss 2021;:1-10. [PMID: 33868899 DOI: 10.1007/s10389-021-01537-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
382 Zou F, Qian Z, Wang Y, Zhao Y, Bai J. Cardiac Injury and COVID-19: A Systematic Review and Meta-analysis. CJC Open 2020;2:386-94. [PMID: 32838255 DOI: 10.1016/j.cjco.2020.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
383 Kalra RS, Tomar D, Meena AS, Kandimalla R. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. Pathogens 2020;9:E546. [PMID: 32645974 DOI: 10.3390/pathogens9070546] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
384 Pergolizzi JV Jr, Varrassi G, Magnusson P, LeQuang JA, Leopoulou M, Paladini A, Taylor R, Wollmuth C, Breve F; NEMA Research Group. The concern about ACE/ARB and COVID-19: Time to hold your horses! J Am Pharm Assoc (2003) 2020;60:e88-90. [PMID: 32747165 DOI: 10.1016/j.japh.2020.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
385 Kottlors J, Große Hokamp N, Fervers P, Bremm J, Fichter F, Persigehl T, Safarov O, Maintz D, Tritt S, Abdullayev N. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome - A multicenter feasibility study. Bone 2021;144:115790. [PMID: 33301962 DOI: 10.1016/j.bone.2020.115790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Quinaglia T, Shabani M, Rezaei N. COVID-19 in Patients with Hypertension. Adv Exp Med Biol 2021;1318:243-61. [PMID: 33973183 DOI: 10.1007/978-3-030-63761-3_15] [Reference Citation Analysis]
387 Goyal P, Sachdeva RA, Parashar L, Sikary AK, Tarique A. Are numbers deceptive? Is death auditing a solution for death analysis, among the COVID-19 deceased?: A study from a dedicated COVID-19 hospital in Faridabad, Haryana. J Family Med Prim Care 2021;10:1347-52. [PMID: 34041177 DOI: 10.4103/jfmpc.jfmpc_2063_20] [Reference Citation Analysis]
388 Carboni E, Carta AR, Carboni E. Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? Med Hypotheses. 2020;140:109776. [PMID: 32344313 DOI: 10.1016/j.mehy.2020.109776] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 36.0] [Reference Citation Analysis]
389 Li Y, Li H, Zhu S, Xie Y, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Sun W, Li M, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Zhang L, Xie M. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc Imaging. 2020;13:2287-2299. [PMID: 32654963 DOI: 10.1016/j.jcmg.2020.04.014] [Cited by in Crossref: 134] [Cited by in F6Publishing: 114] [Article Influence: 134.0] [Reference Citation Analysis]
390 Heck TG, Ludwig MS, Frizzo MN, Rasia-Filho AA, Homem de Bittencourt PI. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies. Clin Sci (Lond) 2020;134:1991-2017. [PMID: 32749472 DOI: 10.1042/CS20200596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
391 Cao X, Yin R, Albrecht H, Fan D, Tan W. Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2? Am J Physiol Endocrinol Metab 2020;319:E197-202. [PMID: 32501731 DOI: 10.1152/ajpendo.00255.2020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 24.0] [Reference Citation Analysis]
392 Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease. Int J Mol Sci 2021;22:1687. [PMID: 33567524 DOI: 10.3390/ijms22041687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
393 Pandey AS, Ringer AJ, Rai A, Kan PT, Jabbour PM, Siddiqui A, Levy E, Snyder KV, Riina HA, Tanweer O, Levitt MR, Kim LJ, Veznedaroglu E, Binning M, Arthur AS, Mocco J, Schirmer CM, Thompson BG, Langer D; Endovascular Neurosurgery Research Group (ENRG). Letter: Considerations for Performing Emergent Neurointerventional Procedures in a COVID-19 Environment. Neurosurgery 2020;87:E203-6. [PMID: 32358606 DOI: 10.1093/neuros/nyaa173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
394 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes 2021;11:21. [PMID: 34168110 DOI: 10.1038/s41387-021-00163-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Mangion K, Morrow A, Bagot C, Bayes H, Blyth KG, Church C, Corcoran D, Delles C, Gillespie L, Grieve D, Ho A, Kean S, Lang NN, Lennie V, Lowe DJ, Kellman P, Macfarlane PW, McConnachie A, Roditi G, Sykes R, Touyz RM, Sattar N, Wereski R, Wright S, Berry C. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovasc Res 2020;116:2185-96. [PMID: 32702087 DOI: 10.1093/cvr/cvaa209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
396 Haybar H, Kazemnia K, Rahim F. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review. Jundishapur J Chronic Dis Care 2020;9. [DOI: 10.5812/jjcdc.103452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
397 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
398 Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, Vassiliou VS. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e213594. [PMID: 33787911 DOI: 10.1001/jamanetworkopen.2021.3594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
399 Langnau C, Rohlfing AK, Gekeler S, Günter M, Pöschel S, Petersen-Uribe Á, Jaeger P, Avdiu A, Harm T, Kreisselmeier KP, Castor T, Bakchoul T, Rath D, Gawaz MP, Autenrieth SE, Mueller KAL. Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19. Arterioscler Thromb Vasc Biol 2021;41:2080-96. [PMID: 33910372 DOI: 10.1161/ATVBAHA.120.315698] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Sheth AR, Grewal US, Patel HP, Thakkar S, Garikipati S, Gaddam J, Bawa D. Possible mechanisms responsible for acute coronary events in COVID-19. Med Hypotheses 2020;143:110125. [PMID: 32763657 DOI: 10.1016/j.mehy.2020.110125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
401 Ho JS, Tambyah PA, Ho AF, Chan MY, Sia CH. Effect of coronavirus infection on the human heart: A scoping review. Eur J Prev Cardiol 2020;27:1136-48. [PMID: 32423250 DOI: 10.1177/2047487320925965] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
402 Almutlaq M, Alamro AA, Alroqi F, Barhoumi T. Classical and Counter-Regulatory Renin-Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology. CJC Open 2021;3:1060-74. [PMID: 33875979 DOI: 10.1016/j.cjco.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Alexander SPH, Armstrong JF, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding M. A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol 2020;177:4942-66. [PMID: 32358833 DOI: 10.1111/bph.15094] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 41.0] [Reference Citation Analysis]
404 Huang Z, Cao J, Yao Y, Jin X, Luo Z, Xue Y, Zhu C, Song Y, Wang Y, Zou Y, Qian J, Yu K, Gong H, Ge J. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension. Ann Transl Med. 2020;8:430. [PMID: 32395474 DOI: 10.21037/atm.2020.03.229] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 47.0] [Reference Citation Analysis]
405 Roy S, Mazumder T, Banik S. The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms. SN Compr Clin Med 2020;:1-6. [PMID: 32838148 DOI: 10.1007/s42399-020-00376-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
406 Mahajan K, Chandra KS. Cardiovascular comorbidities and complications associated with coronavirus disease 2019. Med J Armed Forces India 2020;76:253-60. [PMID: 32773926 DOI: 10.1016/j.mjafi.2020.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
407 Cau R, Bassareo P, Saba L. Cardiac Involvement in COVID-19-Assessment with Echocardiography and Cardiac Magnetic Resonance Imaging. SN Compr Clin Med 2020;:1-7. [PMID: 32838139 DOI: 10.1007/s42399-020-00344-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
408 Zhou W, Ye S, Wang W, Li S, Hu Q. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia. J Diabetes Res 2020;2020:3918723. [PMID: 33062712 DOI: 10.1155/2020/3918723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
409 Mansueto G. COVID-19: Brief check through the pathologist's eye (autopsy archive). Pathol Res Pract 2020;216:153195. [PMID: 32890939 DOI: 10.1016/j.prp.2020.153195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
410 Aw D, Woodrow L, Ogliari G, Harwood R. Association of frailty with mortality in older inpatients with Covid-19: a cohort study. Age Ageing 2020;49:915-22. [PMID: 32778870 DOI: 10.1093/ageing/afaa184] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 42.0] [Reference Citation Analysis]
411 Wehbe Z, Hammoud S, Soudani N, Zaraket H, El-Yazbi A, Eid AH. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling. Front Pharmacol 2020;11:836. [PMID: 32581799 DOI: 10.3389/fphar.2020.00836] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
412 Keri VC, Hooda A, Kodan P, R L B, Jorwal P, Wig N. Intricate interplay between Covid-19 and cardiovascular diseases. Rev Med Virol 2021;31:e2188. [PMID: 33128859 DOI: 10.1002/rmv.2188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
413 Costa R, Castagna A, Ruotolo G. COVID-19 and cardiovascular problems in elderly patients: Food for thought. Aging Med (Milton) 2021. [PMID: 33821229 DOI: 10.1002/agm2.12149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. Psychopharmacology of COVID-19. Psychosomatics 2020;61:411-27. [PMID: 32425246 DOI: 10.1016/j.psym.2020.05.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
415 Zhang W, Li C, Xu Y, He B, Hu M, Cao G, Li L, Wu S, Wang X, Zhang C, Zhao J, Xie J, Xu Z, Li Q, Wang G. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediators Inflamm 2021;2021:8812304. [PMID: 33814982 DOI: 10.1155/2021/8812304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Rabinovitz B, Jaywant A, Fridman CB. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic. Clin Neuropsychol 2020;34:1453-79. [PMID: 32901580 DOI: 10.1080/13854046.2020.1803408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
417 Atlante S, Mongelli A, Barbi V, Martelli F, Farsetti A, Gaetano C. The epigenetic implication in coronavirus infection and therapy. Clin Epigenetics 2020;12:156. [PMID: 33087172 DOI: 10.1186/s13148-020-00946-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
418 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Reference Citation Analysis]
419 Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Acta Diabetol 2020;57:1275-85. [PMID: 32865671 DOI: 10.1007/s00592-020-01586-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
420 Kamyshnyi A, Krynytska I, Matskevych V, Marushchak M, Lushchak O. Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology. Int J Hypertens 2020;2020:8019360. [PMID: 33489355 DOI: 10.1155/2020/8019360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
421 Pérez-Cruz E, Castañón-González JA, Ortiz-Gutiérrez S, Garduño-López J, Luna-Camacho Y. Impact of obesity and diabetes mellitus in critically ill patients with SARS-CoV-2. Obes Res Clin Pract 2021;15:402-5. [PMID: 34016569 DOI: 10.1016/j.orcp.2021.05.001] [Reference Citation Analysis]
422 Polat V, Bozcali E, Yasar KK, Karaosmanoglu HK, Akturk IF. Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity. Arq Bras Cardiol 2021:S0066-782X2021005009206. [PMID: 34231797 DOI: 10.36660/abc.20200724] [Reference Citation Analysis]
423 Parveen R, Sehar N, Bajpai R, Agarwal NB. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis. Diabetes Res Clin Pract 2020;166:108295. [PMID: 32623032 DOI: 10.1016/j.diabres.2020.108295] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
424 Gendelman O, Amital H, Bragazzi NL, Watad A, Chodick G. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. Autoimmun Rev. 2020;19:102566. [PMID: 32380315 DOI: 10.1016/j.autrev.2020.102566] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 41.0] [Reference Citation Analysis]
425 Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: A systematic review and meta-analysis. J Med Virol 2021;93:257-61. [PMID: 32603481 DOI: 10.1002/jmv.26237] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 44.0] [Reference Citation Analysis]
426 Santopaolo M, Sullivan N, Thomas AC, Alvino VV, Nicholson LB, Gu Y, Spinetti G, Kallikourdis M, Blom A, Madeddu P. Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept. Front Immunol 2021;12:609406. [PMID: 33746953 DOI: 10.3389/fimmu.2021.609406] [Reference Citation Analysis]
427 Liu Z, Li J, Li M, Chen S, Gao R, Zeng G, Chen D, Wang S, Li Q, Hu D, Zeng W, Guo L, Wu X. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Fail 2021;8:644-51. [PMID: 33336560 DOI: 10.1002/ehf2.13151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Pericàs JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, Falces C, Marcos MA, Tuset M, Vilella A, Moreno A, Miro JM; Hospital Clínic Cardiovascular Infections Study Group. COVID-19: from epidemiology to treatment. Eur Heart J 2020;41:2092-112. [PMID: 32511724 DOI: 10.1093/eurheartj/ehaa462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 38.0] [Reference Citation Analysis]
429 Leon-Abarca JA, Portmann-Baracco A, Bryce-Alberti M, Ruiz-Sánchez C, Accinelli RA, Soliz J, Gonzales GF. Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients. PLoS One 2021;16:e0255144. [PMID: 34343179 DOI: 10.1371/journal.pone.0255144] [Reference Citation Analysis]
430 Jamwal S, Gautam A, Elsworth J, Kumar M, Chawla R, Kumar P. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic. Life Sci 2020;257:118105. [PMID: 32687917 DOI: 10.1016/j.lfs.2020.118105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 23.0] [Reference Citation Analysis]
431 Kao TW, Huang CC. Recent Progress in Metabolic Syndrome Research and Therapeutics. Int J Mol Sci 2021;22:6862. [PMID: 34202257 DOI: 10.3390/ijms22136862] [Reference Citation Analysis]
432 Nigro E, Polito R, Alfieri A, Mancini A, Imperlini E, Elce A, Krustrup P, Orrù S, Buono P, Daniele A. Molecular mechanisms involved in the positive effects of physical activity on coping with COVID-19. Eur J Appl Physiol 2020;120:2569-82. [PMID: 32885275 DOI: 10.1007/s00421-020-04484-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
433 Roganović J. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19. Med Hypotheses 2021;146:110448. [PMID: 33338955 DOI: 10.1016/j.mehy.2020.110448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Secco GG, Tarantini G, Mazzarotto P, Garbo R, Parisi R, Maggio S, Vercellino M, Pistis G, Audo A, Kozel D, Centini G, Di Mario C. Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience. Catheter Cardiovasc Interv 2021;97:195-8. [PMID: 32400049 DOI: 10.1002/ccd.28959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
435 Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S. COVID-19: the endocrine opportunity in a pandemic. Minerva Endocrinol 2020;45:204-27. [PMID: 32548995 DOI: 10.23736/S0391-1977.20.03216-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
436 Jeong IK, Yoon KH, Lee MK. Diabetes and COVID-19: Global and regional perspectives. Diabetes Res Clin Pract 2020;166:108303. [PMID: 32623038 DOI: 10.1016/j.diabres.2020.108303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
437 Yin T, Li Y, Ying Y, Luo Z. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. BMC Infect Dis 2021;21:200. [PMID: 33618678 DOI: 10.1186/s12879-021-05915-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
438 Morales-Franco B, Nava-Villalba M, Medina-Guerrero EO, Sánchez-Nuño YA, Davila-Villa P, Anaya-Ambriz EJ, Charles-Niño CL. Host-Pathogen Molecular Factors Contribute to the Pathogenesis of Rhizopus spp. in Diabetes Mellitus. Curr Trop Med Rep 2021;:1-12. [PMID: 33500877 DOI: 10.1007/s40475-020-00222-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
439 Kountouri A, Korakas E, Ikonomidis I, Raptis A, Tentolouris N, Dimitriadis G, Lambadiari V. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants (Basel) 2021;10:752. [PMID: 34065123 DOI: 10.3390/antiox10050752] [Reference Citation Analysis]
440 Loh YC, Chan SY, Oo CW, Yam MF. Discovery of trans-3,4,4'-trihydroxystilbene as new lead vasorelaxant agent for antihypertensive drug development. Life Sci 2021;278:119560. [PMID: 33915131 DOI: 10.1016/j.lfs.2021.119560] [Reference Citation Analysis]
441 Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, Pal I, Patel N, Amgai B, Ghosh RK, Fonarow GC, Lavie CJ, Naidu SS. COVID-19 Pandemic: Cardiovascular Complications and Future Implications. Am J Cardiovasc Drugs. 2020;20:311-324. [PMID: 32578167 DOI: 10.1007/s40256-020-00420-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 40.0] [Reference Citation Analysis]
442 Askin L, Tanrıverdi O, Askin HS. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases. Arq Bras Cardiol 2020;114:817-22. [PMID: 32491073 DOI: 10.36660/abc.20200273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 13.0] [Reference Citation Analysis]
443 Suzuki YJ, Nikolaienko SI, Shults NV, Gychka SG. COVID-19 patients may become predisposed to pulmonary arterial hypertension. Med Hypotheses 2021;147:110483. [PMID: 33444904 DOI: 10.1016/j.mehy.2021.110483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
444 Harikrishnan S, Mohanan PP, Chopra VK, Ambuj R, Sanjay G, Bansal M, Chakraborty RN, Chandra S, Chattarjee SS, Chopra HK, Mathew C, Deb PK, Goyal A, Goswami KC, Gupta R, Guha S, Gupta V, Hasija PK, Wardhan H, Jabir A, Jayagopal PB, Kahali D, Katyal VK, Kerkar PG, Khanna NN, Majumder B, Mandal M, Meena CB, Naik N, Narain VK, Pathak LA, Ray S, Roy D, Routray SN, Sarma D, Shanmugasundaram S, Singh BP, Tyagi SK, Venugopal K, Wander GS, Yadav R, Das MK. Cardiological society of India position statement on COVID-19 and heart failure. Indian Heart J 2020;72:75-81. [PMID: 32405088 DOI: 10.1016/j.ihj.2020.04.012] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
445 Aggarwal G, Cheruiyot I, Aggarwal S, Wong J, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. Curr Probl Cardiol 2020;45:100617. [PMID: 32402515 DOI: 10.1016/j.cpcardiol.2020.100617] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 65.0] [Reference Citation Analysis]
446 Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: A review. Dermatol Ther 2020;33:e13549. [PMID: 32390279 DOI: 10.1111/dth.13549] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 67.0] [Reference Citation Analysis]
447 Kaki A, Singh H, Cohen G, Schreiber T. A case report of a large intracardiac thrombus in a COVID-19 patient managed with percutaneous thrombectomy and right ventricular mechanical circulatory support. Eur Heart J Case Rep 2020;4:1-5. [PMID: 33437917 DOI: 10.1093/ehjcr/ytaa308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
448 Helvaci N, Eyupoglu ND, Karabulut E, Yildiz BO. Prevalence of Obesity and Its Impact on Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:598249. [PMID: 33716962 DOI: 10.3389/fendo.2021.598249] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
449 Alqahtani SA, Alnaami I, Alhazzani A. Protected Stroke Mechanical Thrombectomy Code During the Coronavirus (COVID-19) Pandemic: Southwestern Part of Saudi Arabia Stroke Unit Local Protocol. Cureus 2020;12:e7808. [PMID: 32351864 DOI: 10.7759/cureus.7808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
450 Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc 2020;30:100631. [PMID: 32904969 DOI: 10.1016/j.ijcha.2020.100631] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
451 Mahumud RA, Kamara JK, Renzaho AMN. The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis. Infection 2020;48:813-33. [PMID: 32813220 DOI: 10.1007/s15010-020-01502-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
452 Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc 2020;95:1467-81. [PMID: 32622450 DOI: 10.1016/j.mayocp.2020.05.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
453 Asmelash D, Fasil A, Tegegne Y, Akalu TY, Ferede HA, Aynalem GL. Knowledge, Attitudes and Practices Toward Prevention and Early Detection of COVID-19 and Associated Factors Among Religious Clerics and Traditional Healers in Gondar Town, Northwest Ethiopia: A Community-Based Study. Risk Manag Healthc Policy 2020;13:2239-50. [PMID: 33117002 DOI: 10.2147/RMHP.S277846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
454 Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253:117723. [PMID: 32360126 DOI: 10.1016/j.lfs.2020.117723] [Cited by in Crossref: 127] [Cited by in F6Publishing: 94] [Article Influence: 127.0] [Reference Citation Analysis]
455 Rezel-Potts E, Douiri A, Chowienczyk PJ, Gulliford MC. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom. Br J Clin Pharmacol 2021. [PMID: 33908074 DOI: 10.1111/bcp.14873] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
456 Rashad A, Mousa S, Nafady-Hego H, Nafady A, Elgendy H. Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab. Sci Rep 2021;11:8816. [PMID: 33893337 DOI: 10.1038/s41598-021-88086-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
457 Millar JA, Dao HDN, Stefopulos ME, Estevam CG, Fagan-Garcia K, Taft DH, Park C, Alruwaily A, Desai AN, Majumder MS. Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave. medRxiv 2021:2021. [PMID: 33655256 DOI: 10.1101/2021.02.24.21252135] [Reference Citation Analysis]
458 Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokereti J, Tang B. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis. Arch Med Res 2020;51:700-9. [PMID: 32811670 DOI: 10.1016/j.arcmed.2020.07.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
459 Al-Rabia MW, Alhakamy NA, Ahmed OAA, Eljaaly K, Aloafi AL, Mostafa A, Asfour HZ, Aldarmahi AA, Darwish KM, Ibrahim TS, Fahmy UA. Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies. Pharmaceutics 2021;13:307. [PMID: 33652894 DOI: 10.3390/pharmaceutics13030307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
460 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
461 Lü M, Qiu L, Jia G, Guo R, Leng Q. Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2. Aging (Albany NY) 2020;12:19880-97. [PMID: 33104520 DOI: 10.18632/aging.104015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
462 Liu J, Virani SS, Alam M, Denktas AE, Hamzeh I, Khalid U. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol 2021;31:e2172. [PMID: 32959951 DOI: 10.1002/rmv.2172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
463 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020;14:247-50. [PMID: 32247212 DOI: 10.1016/j.dsx.2020.03.013] [Cited by in Crossref: 305] [Cited by in F6Publishing: 221] [Article Influence: 305.0] [Reference Citation Analysis]
465 Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. J Am Heart Assoc 2020;9:e017787. [PMID: 32713239 DOI: 10.1161/JAHA.120.017787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
466 Saha A, Ahsan MM, Quader TU, Shohan MUS, Naher S, Dutta P, Akash AS, Mehedi HMH, Chowdhury AAU, Karim H, Rahman T, Parvin A. Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study. J Prev Med Hyg 2021;62:E33-45. [PMID: 34322614 DOI: 10.15167/2421-4248/jpmh2021.62.1.1838] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg 2020;35:1302-5. [PMID: 32306491 DOI: 10.1111/jocs.14538] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 57.0] [Reference Citation Analysis]
468 Saha A, Ahsan MM, Quader MT, Naher S, Akter F, Mehedi HMH, Ullah Chowdhury AA, Karim MH, Rahman T, Parvin A. Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh. Diabetes Metab Syndr 2021;15:229-35. [PMID: 33445071 DOI: 10.1016/j.dsx.2020.12.037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 An X, Duan L, Zhang YH, Jin, Zhao S, Zhou RR, Duan Y, Lian F, Tong X. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med 2021;16:44. [PMID: 34099015 DOI: 10.1186/s13020-021-00454-x] [Reference Citation Analysis]
470 Baptiste DL, Commodore-Mensah Y, Alexander KA, Jacques K, Wilson PR, Akomah J, Sharps P, Cooper LA. COVID-19: Shedding light on racial and health inequities in the USA. J Clin Nurs 2020;29:2734-6. [PMID: 32472591 DOI: 10.1111/jocn.15351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
471 Bashir S, Alabdulkarim N, Altwaijri N, Alhaidri N, Hashim R, Nasim E, Mir A, Albaradie R, Habib SS, Abualait T. The battle against the COVID-19 pandemic- a perspective from Saudi Arabia. One Health 2021;12:100229. [PMID: 33614883 DOI: 10.1016/j.onehlt.2021.100229] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
472 Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M, Wippermann J, Michels G. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses 2021;13:1346. [PMID: 34372552 DOI: 10.3390/v13071346] [Reference Citation Analysis]
473 Wu BB, Gu DZ, Yu JN, Yang J, Shen WQ. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis. Infect Genet Evol 2020;84:104485. [PMID: 32739464 DOI: 10.1016/j.meegid.2020.104485] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 51.0] [Reference Citation Analysis]
474 Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, Di Giusto F, Loria V, Aspromonte N. 2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications. Chronic Dis Transl Med 2020;6:246-50. [PMID: 32837764 DOI: 10.1016/j.cdtm.2020.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
475 Khan IH, Zahra SA, Zaim S, Harky A. At the heart of COVID-19. J Card Surg 2020;35:1287-94. [PMID: 32369872 DOI: 10.1111/jocs.14596] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
476 Catalfamo CJ, Heslin KM, Shilen A, Khan SM, Hunsaker JR, Austhof E, Barraza L, Cordova-Marks FM, Farland LV, Garcia-Filion P, Hoskinson J, Jehn M, Kohler LN, Lutrick K, Harris RB, Chen Z, Klimentidis YC, Bell ML, Ernst KC, Jacobs ET, Pogreba-Brown K. Design of the Arizona CoVHORT: A Population-Based COVID-19 Cohort. Front Public Health 2021;9:620060. [PMID: 33643990 DOI: 10.3389/fpubh.2021.620060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
477 Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. WJV 2021;10:275-87. [DOI: 10.5501/wjv.v10.i5.275] [Reference Citation Analysis]
478 Mohammed M, Muhammad S, Mohammed FZ, Mustapha S, Sha'aban A, Sani NY, Ahmad MH, Bala AA, Ungogo MA, Alotaibi NM, Zainal H. Risk Factors Associated with Mortality Among Patients with Novel Coronavirus Disease (COVID-19) in Africa. J Racial Ethn Health Disparities 2020. [PMID: 33051749 DOI: 10.1007/s40615-020-00888-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
479 Flaherty GT, Hession P, Liew CH, Lim BCW, Leong TK, Lim V, Sulaiman LH. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines 2020;6:16. [PMID: 32868984 DOI: 10.1186/s40794-020-00118-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
480 Ogah OS, Umuerri EM, Adebiyi A, Orimolade OA, Sani MU, Ojji DB, Mbakwem AC, Stewart S, Sliwa K. SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. Glob Heart 2021;16:18. [PMID: 33833942 DOI: 10.5334/gh.829] [Reference Citation Analysis]
481 Heberto AB, Carlos PCJ, Antonio CRJ, Patricia PP, Enrique TR, Danira MPJ, Benito GÁE, Alfredo MRJ. Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19). Int J Cardiol Heart Vasc 2020;30:100638. [PMID: 32953968 DOI: 10.1016/j.ijcha.2020.100638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
482 Wurth R, Hajdenberg M, Barrera FJ, Shekhar S, Copacino CE, Moreno-Peña PJ, Gharib OAM, Porter F, Hiremath S, Hall JE, Schiffrin EL, Eisenhofer G, Bornstein SR, Brito JP, González-González JG, Stratakis CA, Rodríguez-Gutiérrez R, Hannah-Shmouni F. Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? Postgrad Med J 2021:postgradmedj-2020-139392. [PMID: 33637639 DOI: 10.1136/postgradmedj-2020-139392] [Reference Citation Analysis]
483 Yan H, Lu S, Chen L, Wang Y, Liu Q, Li D, Yan X, Yan J. Multiple organ injury on admission predicts in-hospital mortality in patients with COVID-19. J Med Virol 2021;93:1652-64. [PMID: 32949175 DOI: 10.1002/jmv.26534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
484 Jakhmola S, Indari O, Baral B, Kashyap D, Varshney N, Das A, Chatterjee S, Jha HC. Comorbidity Assessment Is Essential During COVID-19 Treatment. Front Physiol 2020;11:984. [PMID: 32903640 DOI: 10.3389/fphys.2020.00984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
485 Scudiero O, Lombardo B, Brancaccio M, Mennitti C, Cesaro A, Fimiani F, Gentile L, Moscarella E, Amodio F, Ranieri A, Gragnano F, Laneri S, Mazzaccara C, Di Micco P, Caiazza M, D'Alicandro G, Limongelli G, Calabrò P, Pero R, Frisso G. Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination. Int J Environ Res Public Health 2021;18:904. [PMID: 33494244 DOI: 10.3390/ijerph18030904] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
486 Bonora E, Fedeli U, Schievano E, Trombetta M, Saia M, Scroccaro G, Tacconelli E, Zoppini G. SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people. Nutr Metab Cardiovasc Dis 2021;31:2612-8. [PMID: 34348880 DOI: 10.1016/j.numecd.2021.06.010] [Reference Citation Analysis]
487 Onorato D, Carpenè G, Lippi G, Pucci M. Updated overview on the interplay between obesity and COVID-19. Diagnosis (Berl) 2021;8:5-16. [PMID: 33544485 DOI: 10.1515/dx-2020-0111] [Reference Citation Analysis]
488 Couderc AL, Correard F, Hamidou Z, Nouguerede E, Arcani R, Weiland J, Courcier A, Caunes P, Clot-Faybesse P, Gil P, Berard C, Miola C, Berbis J, Villani P, Daumas A. Factors Associated With COVID-19 Hospitalizations and Deaths in French Nursing Homes. J Am Med Dir Assoc 2021;22:1581-1587.e3. [PMID: 34237258 DOI: 10.1016/j.jamda.2021.06.023] [Reference Citation Analysis]
489 Catapano F, Marchitelli L, Cundari G, Cilia F, Mancuso G, Pambianchi G, Galea N, Ricci P, Catalano C, Francone M. Role of advanced imaging in COVID-19 cardiovascular complications. Insights Imaging 2021;12:28. [PMID: 33625637 DOI: 10.1186/s13244-021-00973-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
490 Ford JS, Parikh A, Sandhu R, Turnipseed S, Morris B, May L, Holmes JF. Testing Asymptomatic Emergency Department Patients for Coronavirus Disease 2019 (COVID-19) in a Low-prevalence Region. Acad Emerg Med 2020;27:771-4. [PMID: 32516467 DOI: 10.1111/acem.14044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
491 Zuin M, Rigatelli G, Zuliani G, Bilato C, Zonzin P, Roncon L. Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. Journal of Cardiovascular Medicine 2020;21:759-64. [DOI: 10.2459/jcm.0000000000001064] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
492 Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Impact of COVID-19 on the Cardiovascular System: A Review. J Clin Med 2020;9:E1407. [PMID: 32397558 DOI: 10.3390/jcm9051407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
493 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 37.0] [Reference Citation Analysis]
494 Atchie B, Jarvis S, Stoddard E, Salottolo K, Nieberlein A, McCarthy K, Bartt R, Bennett A, Burrell C, Frei D, Bar-Or D. Implementing the SNIS recommendations for neurointerventional emergent care in the setting of COVID-19: impact on stroke metrics and patient outcomes. J Neurointerv Surg 2021:neurintsurg-2021-017415. [PMID: 33758066 DOI: 10.1136/neurintsurg-2021-017415] [Reference Citation Analysis]
495 Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol 2020;75:2352-71. [PMID: 32201335 DOI: 10.1016/j.jacc.2020.03.031] [Cited by in Crossref: 770] [Cited by in F6Publishing: 650] [Article Influence: 770.0] [Reference Citation Analysis]
496 Zhou M, Wong CK, Un KC, Lau YM, Lee JC, Tam FC, Lau YM, Lai WH, Tam AR, Lam YY, Pang P, Tong T, Tang M, Tse HF, Ho D, Ng MY, Chan EW, Wong ICK, Lau CP, Hung IF, Siu CW. Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS One 2021;16:e0246732. [PMID: 33571321 DOI: 10.1371/journal.pone.0246732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
497 Howard MB, Basu S, Sherwin E, Cohen JS. Triple threat: New presentation with diabetic ketoacidosis, COVID-19, and cardiac arrhythmias. Am J Emerg Med 2021:S0735-6757(21)00331-4. [PMID: 33895040 DOI: 10.1016/j.ajem.2021.04.045] [Reference Citation Analysis]
498 Grover A, Oberoi M. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Eur Heart J Cardiovasc Pharmacother. 2021;7:148-157. [PMID: 32542337 DOI: 10.1093/ehjcvp/pvaa064] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
499 Park KH, Kim AR, Yang MA, Lim SJ, Park JH. Impact of the COVID-19 pandemic on the lifestyle, mental health, and quality of life of adults in South Korea. PLoS One 2021;16:e0247970. [PMID: 33635897 DOI: 10.1371/journal.pone.0247970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
500 Amirfakhryan H, Safari F. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement. Hellenic J Cardiol 2021;62:13-23. [PMID: 32522617 DOI: 10.1016/j.hjc.2020.05.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
501 Soto M, diZerega G, Rodgers KE. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320972018. [PMID: 33169644 DOI: 10.1177/1470320320972018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
502 Chee YJ, Tan SK, Yeoh E. Dissecting the interaction between COVID-19 and diabetes mellitus. J Diabetes Investig 2020;11:1104-14. [PMID: 32558211 DOI: 10.1111/jdi.13326] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
503 Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, Guan X, Gary T, Zhu Z. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart 2020;106:1142-7. [PMID: 32461330 DOI: 10.1136/heartjnl-2020-317062] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 58.0] [Reference Citation Analysis]
504 Rosen HR, O'Connell C, Nadim MK, DeClerck B, Sheibani S, DePasquale E, Sanossian N, Blodget E, Angell T. Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection. J Med Virol 2021;93:2645-53. [PMID: 33090515 DOI: 10.1002/jmv.26595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
505 Weizman O, Mika D, Cellier J, Geneste L, Trimaille A, Pommier T, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Duceau B, Sutter W, Fauvel C, Pezel T, Bonnet G, Cohen A, Waldmann V; Critical COVID-19 France Investigators. Characteristics and impact of cardiovascular comorbidities on coronavirus disease 2019 in women: A multicentre cohort study. Arch Cardiovasc Dis 2021;114:394-406. [PMID: 34154954 DOI: 10.1016/j.acvd.2021.04.002] [Reference Citation Analysis]
506 Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry. Viruses 2021;13:1246. [PMID: 34206990 DOI: 10.3390/v13071246] [Reference Citation Analysis]
507 Gazzaz ZJ. Diabetes and COVID-19. Open Life Sci 2021;16:297-302. [PMID: 33817321 DOI: 10.1515/biol-2021-0034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
508 Cameli M, Pastore MC, Mandoli GE, D'Ascenzi F, Focardi M, Biagioni G, Cameli P, Patti G, Franchi F, Mondillo S, Valente S. COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications. Front Cardiovasc Med 2020;7:593496. [PMID: 33585577 DOI: 10.3389/fcvm.2020.593496] [Reference Citation Analysis]
509 Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne) 2021;12:649525. [PMID: 34220706 DOI: 10.3389/fendo.2021.649525] [Reference Citation Analysis]
510 Frattini S, Maccagni G, Italia L, Metra M, Danzi GB. Coronavirus disease 2019 and cardiovascular implications. J Cardiovasc Med (Hagerstown) 2020;21:725-32. [PMID: 32858623 DOI: 10.2459/JCM.0000000000001068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
511 Abate SM, Checkol YA, Mantefardo B. Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis. Ann Med Surg (Lond) 2021;64:102204. [PMID: 33692899 DOI: 10.1016/j.amsu.2021.102204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
512 Barabari P, Moharamzadeh K. Novel Coronavirus (COVID-19) and Dentistry-A Comprehensive Review of Literature. Dent J (Basel) 2020;8:E53. [PMID: 32455612 DOI: 10.3390/dj8020053] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 46.0] [Reference Citation Analysis]
513 Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere JM, Aguilhon S, Gueffet JP, Salvat M, Damy T, Galinier M; Heart Failure Group of the French Society of Cardiology. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis 2021;114:434-8. [PMID: 34099378 DOI: 10.1016/j.acvd.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
514 Turan T, Özderya A, Şahin S, Konuş AH, Kul S, Akyüz AR, Kalaycıoğlu E, Sayın MR. Left ventricular global longitudinal strain in low cardiac risk outpatients who recently recovered from coronavirus disease 2019. Int J Cardiovasc Imaging 2021. [PMID: 34387799 DOI: 10.1007/s10554-021-02376-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Chen L, Upadhya G, Guo US, Belligund P, Lee DK, Shalom I, Dubey GR, Al-Ajam MR, Mitre CA. Novel Coronavirus-Induced Right Ventricular Failure and Point of Care Echocardiography: A Case Report. Cardiology 2020;145:467-72. [PMID: 32450565 DOI: 10.1159/000508527] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
516 Sukkar SG, Cogorno L, Pisciotta L, Pasta A, Vena A, Gradaschi R, Dentone C, Guiddo E, Martino E, Beltramini S, Donini LM, Carmisciano L, Sormani MP, Bassetti M; GECOVID Study Group. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition 2021;89:111236. [PMID: 33895559 DOI: 10.1016/j.nut.2021.111236] [Reference Citation Analysis]
517 Wei ZY, Qiao R, Chen J, Huang J, Wu H, Wang WJ, Yu H, Xu J, Wang C, Gu CH, Li HJ, Li M, Liu C, Yang J, Wang Y, Wang HY, Qian HY, Geng YJ. The influence of pre-existing hypertension on coronavirus disease 2019 patients. Epidemiol Infect 2021;149:e4. [PMID: 33397519 DOI: 10.1017/S0950268820003118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 2020;22:171. [PMID: 33040241 DOI: 10.1007/s11886-020-01421-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
519 Mitacchione G, Schiavone M, Curnis A, Arca M, Antinori S, Gasperetti A, Mascioli G, Severino P, Sabato F, Caracciolo MM, Arabia G, D'Erasmo L, Viecca M, Mancone M, Galli M, Forleo GB. Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy. J Clin Lipidol 2021;15:68-78. [PMID: 33390341 DOI: 10.1016/j.jacl.2020.12.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
520 Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL; COVID-19 ID Team. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020;7:e554-64. [PMID: 32473657 DOI: 10.1016/S2352-3018(20)30164-8] [Cited by in Crossref: 118] [Cited by in F6Publishing: 56] [Article Influence: 118.0] [Reference Citation Analysis]
521 Das S, K R A, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Life Sci 2020;258:118202. [PMID: 32758625 DOI: 10.1016/j.lfs.2020.118202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
522 Yang M, Dong Y, He Q, Zhu P, Zhuang Q, Shen J, Zhang X, Zhao M. Hydrogen: A Novel Option in Human Disease Treatment. Oxid Med Cell Longev 2020;2020:8384742. [PMID: 32963703 DOI: 10.1155/2020/8384742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
523 Gorecka M, McCann GP, Berry C, Ferreira VM, Moon JC, Miller CA, Chiribiri A, Prasad S, Dweck MR, Bucciarelli-Ducci C, Dawson D, Fontana M, Macfarlane PW, McConnachie A, Neubauer S, Greenwood JP; COVID-HEART investigators. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J Cardiovasc Magn Reson 2021;23:77. [PMID: 34112195 DOI: 10.1186/s12968-021-00752-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Ferreira C, Viana SD, Reis F. Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches. Microorganisms. 2020;8. [PMID: 33019592 DOI: 10.3390/microorganisms8101514] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
525 Barrera FJ, Shekhar S, Wurth R, Moreno-Pena PJ, Ponce OJ, Hajdenberg M, Alvarez-Villalobos NA, Hall JE, Schiffrin EL, Eisenhofer G, Porter F, Brito JP, Bornstein SR, Stratakis CA, González-González JG, Rodíguez-Gutiérrez R, Hannah-Shmouni F. Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients. J Endocr Soc 2020;4:bvaa102. [PMID: 32885126 DOI: 10.1210/jendso/bvaa102] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
526 Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, Gidding SS, Ojji D, Hakim F, Newby LK, Stępińska J, Lam CSP, Jobe M, Kraus S, Chuquiure-Valenzuela E, Piñeiro D, Khaw KT, Bahiru E, Banerjee A, Narula J, Pinto FJ, Wood DA, Sliwa K. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Glob Heart 2020;15:44. [PMID: 32923338 DOI: 10.5334/gh.823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
527 López-Bueno R, Torres-Castro R, Koyanagi A, Smith L, Soysal P, Calatayud J. Associations between recently diagnosed conditions and hospitalization due to COVID-19 in patients aged 50 years and older- A SHARE-based analysis. J Gerontol A Biol Sci Med Sci 2021:glab199. [PMID: 34251451 DOI: 10.1093/gerona/glab199] [Reference Citation Analysis]
528 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
529 Driggin E, Maddox TM, Ferdinand KC, Kirkpatrick JN, Ky B, Morris AA, Mullen JB, Parikh SA, Philbin DM Jr, Vaduganathan M. ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021;77:1938-1948. [PMID: 33587998 DOI: 10.1016/j.jacc.2021.02.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
530 Kicska G, Litmanovich DE, Ordovas KG, Young PM, Dennie C, Truong QA, Abbara S, Kirsch J. Statement from the North American Society for Cardiovascular Imaging on imaging strategies to reduce the scarcity of healthcare resources during the COVID-19 outbreak. Int J Cardiovasc Imaging 2020;36:1387-93. [PMID: 32474676 DOI: 10.1007/s10554-020-01861-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
531 Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of covid-19? BMJ. 2020;369:m1548. [PMID: 32312785 DOI: 10.1136/bmj.m1548] [Cited by in Crossref: 223] [Cited by in F6Publishing: 197] [Article Influence: 223.0] [Reference Citation Analysis]
532 Agarwal S, Agarwal SK. Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications. Cardiovasc Drugs Ther 2021;35:427-40. [PMID: 32918656 DOI: 10.1007/s10557-020-07070-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
533 Raza HA, Tariq J, Agarwal V, Gupta L. COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatol Int 2021;41:257-73. [PMID: 33386447 DOI: 10.1007/s00296-020-04759-2] [Reference Citation Analysis]
534 Ulu S, Gungor O, Gok Oguz E, Hasbal NB, Turgut D, Arici M. COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation? Ren Fail 2020;42:710-25. [PMID: 32713282 DOI: 10.1080/0886022X.2020.1797791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
535 Leso V, Fontana L, Iavicoli I. Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors. Int J Environ Res Public Health 2021;18:1030. [PMID: 33503829 DOI: 10.3390/ijerph18031030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
536 Kamrujjaman M, Mahmud MS, Ahmed S, Qayum MO, Alam MM, Hassan MN, Islam MR, Nipa KF, Bulut U. SARS-CoV-2 and Rohingya Refugee Camp, Bangladesh: Uncertainty and How the Government Took Over the Situation. Biology (Basel) 2021;10:124. [PMID: 33562509 DOI: 10.3390/biology10020124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
537 Sheikh AB, Shekhar R, Javed N, Upadhyay S. Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report. Am J Case Rep 2020;21:e926101. [PMID: 32981926 DOI: 10.12659/AJCR.926101] [Reference Citation Analysis]
538 Mahrooz A, Muscogiuri G, Buzzetti R, Maddaloni E. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine 2021;72:317-25. [PMID: 33886062 DOI: 10.1007/s12020-021-02729-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
539 Lima B, Gibson GT, Vullaganti S, Malhame K, Maybaum S, Hussain ST, Shah S, Majure DT, Wallach F, Jang K, Bijol V, Esposito MJ, Williamson AK, Thomas RM, Bhuiya TA, Fernandez HA, Stevens GR. COVID-19 in recent heart transplant recipients: Clinicopathologic features and early outcomes. Transpl Infect Dis 2020;22:e13382. [PMID: 32583620 DOI: 10.1111/tid.13382] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
540 Cuschieri S, Grech S. Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom 2020;5:e6. [PMID: 33282327 DOI: 10.1017/gheg.2020.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
541 Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, Venturini E, Iesu S, Virtuoso N, Strianese A, Ciccarelli M, Galasso G, Vecchione C. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art. Life (Basel) 2021;11:259. [PMID: 33801080 DOI: 10.3390/life11030259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
542 Abuelgasim E, Saw LJ, Shirke M, Zeinah M, Harky A. COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Curr Probl Cardiol 2020;45:100621. [PMID: 32448759 DOI: 10.1016/j.cpcardiol.2020.100621] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 57.0] [Reference Citation Analysis]
543 Unluguzel Ustun G, Keskin A, Aci R, Arslanbek Erdem M, Ari M. Association between Hb A1c and Severity of COVID-19 Patients. Hemoglobin 2021;45:124-8. [PMID: 34162301 DOI: 10.1080/03630269.2021.1926278] [Reference Citation Analysis]
544 Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, Seidu S, Zaccardi F, Davies MJ, Khunti K. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab 2020;22:1915-24. [PMID: 32573903 DOI: 10.1111/dom.14124] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 92.0] [Reference Citation Analysis]
545 Mirmohammadi S, Kianmehr A, Arefi M, Mahrooz A. Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran. New Microbes New Infect 2020;38:100792. [PMID: 33101694 DOI: 10.1016/j.nmni.2020.100792] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
546 Brunello A, Galiano A, Finotto S, Monfardini S, Colloca G, Balducci L, Zagonel V. Older cancer patients and COVID-19 outbreak: Practical considerations and recommendations. Cancer Med 2020;9:9193-204. [PMID: 33219746 DOI: 10.1002/cam4.3517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
547 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
548 Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients. Hypertension 2020;76:732-41. [PMID: 32654555 DOI: 10.1161/HYPERTENSIONAHA.120.15289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 25.0] [Reference Citation Analysis]
549 Bansal R, Gubbi S, Muniyappa R. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course. Endocrinology. 2020;161. [PMID: 32603424 DOI: 10.1210/endocr/bqaa112] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 34.0] [Reference Citation Analysis]
550 Priya G, Bajaj S, Grewal E, Maisnam I, Chandrasekharan S, Selvan C. Challenges in Women with Diabetes During the COVID-19 Pandemic. Eur Endocrinol 2020;16:100-8. [PMID: 33117440 DOI: 10.17925/EE.2020.16.2.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
551 Gorini F, Chatzianagnostou K, Mazzone A, Bustaffa E, Esposito A, Berti S, Bianchi F, Vassalle C. "Acute Myocardial Infarction in the Time of COVID-19": A Review of Biological, Environmental, and Psychosocial Contributors. Int J Environ Res Public Health 2020;17:E7371. [PMID: 33050220 DOI: 10.3390/ijerph17207371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
552 Ceriello A, Schnell O. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management. J Diabetes Sci Technol 2020;14:723-4. [PMID: 32475168 DOI: 10.1177/1932296820930025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
553 Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography 2020;37:1454-64. [PMID: 32885490 DOI: 10.1111/echo.14834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
554 Valencia I, Peiró C, Lorenzo Ó, Sánchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Front Pharmacol 2020;11:1161. [PMID: 32848769 DOI: 10.3389/fphar.2020.01161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 22.0] [Reference Citation Analysis]
555 Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar. J Am Coll Cardiol 2020;76:2024-35. [PMID: 33092738 DOI: 10.1016/j.jacc.2020.07.069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
556 Galea N, Marchitelli L, Pambianchi G, Catapano F, Cundari G, Birtolo LI, Maestrini V, Mancone M, Fedele F, Catalano C, Francone M. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study. J Cardiovasc Magn Reson 2021;23:68. [PMID: 34107985 DOI: 10.1186/s12968-021-00764-x] [Reference Citation Analysis]
557 Singh R, Kashyap R, Hutton A, Sharma M, Surani S. A Review of Cardiac Complications in Coronavirus Disease 2019. Cureus 2020;12:e8034. [PMID: 32528770 DOI: 10.7759/cureus.8034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
558 Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 2020;18:205. [PMID: 32430070 DOI: 10.1186/s12967-020-02364-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 67.0] [Reference Citation Analysis]
559 Melesse DY, Chekol WB. The management of patients with coronavirus disease 2019 in intensive care unit (ICU) in low income countries: A review article. Clin Nutr Open Sci 2021;37:60-72. [PMID: 34056632 DOI: 10.1016/j.nutos.2021.05.001] [Reference Citation Analysis]
560 Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol 2020;11:576818. [PMID: 33335527 DOI: 10.3389/fimmu.2020.576818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
561 Barison A, Aimo A, Castiglione V, Arzilli C, Lupón J, Codina P, Santiago-Vacas E, Cediel G, Emdin M, Bayes-Genis A. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol 2020;27:1017-25. [PMID: 32391719 DOI: 10.1177/2047487320924501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
562 de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, Bertoluci MC; Brazilian Diabetes Society Study Group (SBD). Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr 2020;12:75. [PMID: 32874207 DOI: 10.1186/s13098-020-00586-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 45.0] [Reference Citation Analysis]
563 Bassendine MF, Bridge SH, Mccaughan GW, Gorrell MD. COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity? Journal of Diabetes 2020;12:649-58. [DOI: 10.1111/1753-0407.13052] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 51.0] [Reference Citation Analysis]
564 Moula AI, Micali LR, Matteucci F, Lucà F, Rao CM, Parise O, Parise G, Gulizia MM, Gelsomino S. Quantification of Death Risk in Relation to Sex, Pre-Existing Cardiovascular Diseases and Risk Factors in COVID-19 Patients: Let's Take Stock and See Where We Are. J Clin Med 2020;9:E2685. [PMID: 32825068 DOI: 10.3390/jcm9092685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
565 Yang W, Wang C, Shikora S, Kow L. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO. Obes Surg 2020;30:2071-3. [PMID: 32291701 DOI: 10.1007/s11695-020-04578-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 48.0] [Reference Citation Analysis]
566 Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021;22:229-240. [PMID: 33054481 DOI: 10.1080/14656566.2020.1837114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
567 Gupta S, Mitra A. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev 2021. [PMID: 33426593 DOI: 10.1007/s10741-021-10076-y] [Reference Citation Analysis]
568 Fu T, Mamaliga G, Pierce JD, Gilkeson R, Gupta A. COVID-19 infection complicated by acute ST-elevation myocardial infarction. Clin Imaging 2021;78:117-20. [PMID: 33774577 DOI: 10.1016/j.clinimag.2021.03.010] [Reference Citation Analysis]
569 Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin M, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis. J Med Virol 2020;92:2473-88. [PMID: 32530509 DOI: 10.1002/jmv.26166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 31.0] [Reference Citation Analysis]
570 Crook RL, Williams H, Green M, Brown S, Morris R, Fletcher H, Walters S, Walsh C, Price A, King S, McAloon CJ. Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic. Open Heart 2021;8:e001409. [PMID: 33504630 DOI: 10.1136/openhrt-2020-001409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
571 Kirresh A, Coghlan G, Candilio L. COVID-19 Infection and High Intracoronary Thrombus Burden. Cardiovasc Revasc Med 2021;28:82-7. [PMID: 32967797 DOI: 10.1016/j.carrev.2020.07.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
572 Garg N, McClafferty B, Ramgobin D, Golamari R, Jain R, Jain R. Cardiology and COVID-19: do we have sufficient information? Future Cardiol 2021;17:705-11. [PMID: 33124920 DOI: 10.2217/fca-2020-0126] [Reference Citation Analysis]
573 Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. [PMID: 32364264 DOI: 10.1111/his.14134] [Cited by in Crossref: 493] [Cited by in F6Publishing: 419] [Article Influence: 493.0] [Reference Citation Analysis]
574 Fatehi P, Hesam-Shariati N, Abouzaripour M, Fathi F, Hesam Shariati MB. Acute Ischemic and Hemorrhagic Stroke and COVID-19: Case Series. SN Compr Clin Med 2020;:1-6. [PMID: 33024934 DOI: 10.1007/s42399-020-00559-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
575 Du P, Li D, Wang A, Shen S, Ma Z, Li X. A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients. Can J Infect Dis Med Microbiol 2021;2021:6660930. [PMID: 33936349 DOI: 10.1155/2021/6660930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
576 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
577 Kucher AN, Babushkina NP, Sleptcov AA, Nazarenko MS. Genetic Control of Human Infection with SARS-CoV-2. Russ J Genet 2021;57:627-41. [PMID: 34248311 DOI: 10.1134/S1022795421050057] [Reference Citation Analysis]
578 Corrales-Reyes IE, Hernández-García F, Mejia CR. COVID-19 and diabetes: Analysis of the scientific production indexed in Scopus. Diabetes Metab Syndr 2021;15:765-70. [PMID: 33831772 DOI: 10.1016/j.dsx.2021.03.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
579 Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320927851. [PMID: 32431227 DOI: 10.1177/1470320320927851] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
580 Zhu H, Zhang Y, Pei Z, Guo Y, Yang C, Song Y, Guo X, Wang F. Manifestation of cardiac injury in hospitalised patients with COVID-19. Int J Clin Pract 2021;75:e14197. [PMID: 33792126 DOI: 10.1111/ijcp.14197] [Reference Citation Analysis]
581 Sadler D, DeCara JM, Herrmann J, Arnold A, Ghosh AK, Abdel-Qadir H, Yang EH, Szmit S, Akhter N, Leja M, Silva CMPDC, Raikhelkar J, Brown SA, Dent S, O'Quinn R, Thuny F, Moudgil R, Raez LE, Okwuosa T, Daniele A, Bauer B, Kondapalli L, Ismail-Khan R, Lax J, Blaes A, Nahleh Z, Elson L, Baldassarre LA, Zaha V, Rao V, Lara DS, Skurka K; Cardio-Oncology International Collaborative Network. Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey. Cardiooncology 2020;6:28. [PMID: 33292763 DOI: 10.1186/s40959-020-00085-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
582 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 42.0] [Reference Citation Analysis]
583 Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, Vidán-Austiz MT, Formiga F, Ariza-Solé A, Martínez-Sellés M; Los autores firmantes pertenecen a las siguientes entidades científicas. [Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology]. Rev Esp Cardiol 2020;73:569-76. [PMID: 32292226 DOI: 10.1016/j.recesp.2020.03.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 41.0] [Reference Citation Analysis]
584 Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras-Roubin S, Mendez JLJ, Espejo C, López-Masjuan Á, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrishna H, Estrada V, Macaya C, Fernandez-Ortiz A; HOPE COVID-19 Investigators (Cols Appendix). Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Am Heart J 2021;237:104-15. [PMID: 33845032 DOI: 10.1016/j.ahj.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
585 Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C) 2020;2020:2402961. [PMID: 32377638 DOI: 10.34133/2020/2402961] [Cited by in Crossref: 71] [Cited by in F6Publishing: 83] [Article Influence: 71.0] [Reference Citation Analysis]
586 Khan Z, Ualiyeva D, Khan A, Zaman N, Sapkota S, Khan A, Ali B, Ghafoor D. A Correlation among the COVID-19 Spread, Particulate Matters, and Angiotensin-Converting Enzyme 2: A Review. J Environ Public Health 2021;2021:5524098. [PMID: 34054974 DOI: 10.1155/2021/5524098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
587 Teixeira R, Santos M, Gil V. COVID-19 and cardiovascular comorbidities: An update. Rev Port Cardiol (Engl Ed) 2020;39:417-9. [PMID: 32718858 DOI: 10.1016/j.repc.2020.06.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
588 Seiglie JA, Serván-Mori E, Manne-Goehler J, Meigs JB, Miranda JJ, Sosa-Rubí SG, Silverman-Retana O, Wexler DJ, Wirtz VJ. Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study. Diabetes Res Clin Pract 2021;178:108953. [PMID: 34298043 DOI: 10.1016/j.diabres.2021.108953] [Reference Citation Analysis]
589 Alqahtani SA, Aljumah AA, Hashim A, Alenazi TH, AlJawad M, Al Hamoudi WK, Alghamdi MY. Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. Ann Saudi Med. 2020;40:273-280. [PMID: 32564624 DOI: 10.5144/0256-4947.2020.273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
590 de Souto Barreto P, Vellas B, Rolland Y. Physical activity and exercise in the context of SARS-Cov-2: A perspective from geroscience field. Ageing Res Rev 2021;66:101258. [PMID: 33450400 DOI: 10.1016/j.arr.2021.101258] [Reference Citation Analysis]
591 Dobrowolski H, Włodarek D. Body Mass, Physical Activity and Eating Habits Changes during the First COVID-19 Pandemic Lockdown in Poland. Int J Environ Res Public Health 2021;18:5682. [PMID: 34073223 DOI: 10.3390/ijerph18115682] [Reference Citation Analysis]
592 Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, Helmy A, Ghouri N. COVID-19, Diabetes and Ramadan. Diabetes Ther 2020;11:2447-51. [PMID: 32880875 DOI: 10.1007/s13300-020-00887-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
593 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
594 Perl L, Ben Avraham B, Vaknin-Assa H, Ben Gal T, Kornowski R. A rise in left atrial pressure detected by the V-LAP™ system for patients with heart failure during the coronavirus disease 2019 pandemic. ESC Heart Fail 2020. [PMID: 32965779 DOI: 10.1002/ehf2.13033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
595 Dan S, Pant M, Upadhyay SK. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic. Curr Pharmacol Rep 2020;:1-10. [PMID: 32953401 DOI: 10.1007/s40495-020-00239-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
596 Merlo E, Grutta G, Tiberio I, Martelli G. Right Heart Thrombus in an Adult COVID-19 Patient: A Case Report. J Crit Care Med (Targu Mures) 2020;6:237-42. [PMID: 33200095 DOI: 10.2478/jccm-2020-0039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
597 Sattarzadeh Badkoubeh R, Almassi N, Moshkani Farahani M, Movassaghi N, Khosravi A, Mirdamadi A, Kamali M, Manshouri S, Toufan Tabrizi M, Farrashi M, Samiei N; ISE scientific committee. The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID-19 Pandemic. Curr Probl Cardiol 2020;45:100620. [PMID: 32448757 DOI: 10.1016/j.cpcardiol.2020.100620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
598 Nasiri R, Akbarpour S, Zali AR, Khodakarami N, Boochani MH, Noory AR, Soori H. Spatio-temporal analysis of COVID-19 incidence rate using GIS: a case study-Tehran metropolitan, Iran. GeoJournal 2021;:1-15. [PMID: 33994652 DOI: 10.1007/s10708-021-10438-x] [Reference Citation Analysis]
599 [DOI: 10.1101/2020.07.31.20165696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
600 Alali AS, Alshehri AO, Assiri A, Khan S, Alkathiri MA, Almohammed OA, Badoghaish W, AlQahtani SM, Alshammari MA, Mohany M, Alamri FF, AlRuthia Y, Alqahtani F. Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia. Saudi Pharm J 2021;29:833-42. [PMID: 34177315 DOI: 10.1016/j.jsps.2021.06.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
601 Yu Y, Shi Q, Zheng P, Gao L, Li H, Tao P, Gu B, Wang D, Chen H. Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks. J Med Virol 2020;92:883-90. [PMID: 32301508 DOI: 10.1002/jmv.25901] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
602 Kaur H, Thakur JS, Paika R, Advani SM. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2021;22:1333-49. [PMID: 34048161 DOI: 10.31557/APJCP.2021.22.5.1333] [Reference Citation Analysis]
603 Sultan M, Kene D, Waganew W, Worku A, Azazh A, Girma B, Seman Y, Tessema N, Yifru S, Teklu S, Argaw R, Tefera M, Walelegn M, Redae B. Clinical Characteristics of COVID-19 Related Deaths in Ethiopia. Ethiop J Health Sci 2021;31:223-8. [PMID: 34158772 DOI: 10.4314/ejhs.v31i2.3] [Reference Citation Analysis]
604 Purroy F, Arqué G. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One 2021;16:e0252351. [PMID: 34106984 DOI: 10.1371/journal.pone.0252351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
605 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
606 Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H. The cardiovascular aspect of COVID-19. Ann Med 2021;53:227-36. [PMID: 33345626 DOI: 10.1080/07853890.2020.1861644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
607 Mihalj M, Carrel T, Gregoric ID, Andereggen L, Zinn PO, Doll D, Stueber F, Gabriel RA, Urman RD, Luedi MM. Telemedicine for preoperative assessment during a COVID-19 pandemic: Recommendations for clinical care. Best Pract Res Clin Anaesthesiol 2020;34:345-51. [PMID: 32711839 DOI: 10.1016/j.bpa.2020.05.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]